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INTRODUCTION 
Despite advances over the past 30 years in the antibiotic therapy 
of infections caused by Staphylococcus aureus, this organism continues 
to represent a major cause of morbidity and mortality. Infections caused 
by Staphylococcus aureus range from relatively minor skin infections to 
serious contiguous infections, bacteremia and metastatic abscess forma­
tion. Staphylococcus aureus also remains as the leading cause of food 
poisoning. 
Staphylococcus aureus produces what can be regarded as an extra­
cellular armory of various extracellular products. Among these are 
several cytolytic toxins, the enterotoxins, coagulase, thermostable 
nuclease, fibrinolysin, leukocidin, hyaluronidase, lipase, and several 
proteases. Aside from the enterotoxins, it is generally held that none 
of these extracellular products has been shown unequivocally to be a 
major determinant of infection and disease. The mechanism of staphylococcal 
pathogenicity is extremely complex and therefore the role of any one 
product must be viewed in regard to its relative contribution to the 
overall process being examined. Of these several toxins and potentially 
toxic products of Staphylococcus aureus, the most potent is the a-toxin 
(Arbuthnott, 1970). The a-toxin or a-hemolysin of Staphylococcus aureus 
is classified as a cytolytic toxin and because of its striking biological 
effects it has been studied extensively. However, despite recent ad­
vances in our knowledge of this intriguing toxin, the exact nature of 
its substrate and receptor in cell membranes or its true role in the 
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pathogenesis of human disease remain unknown. There is also very 
little known about the genetics of a-toxin production in Staphylococcus 
aureus. The genetic regulation of synthesis of a-toxin, as well as 
many of the other extracellular products of Staphylococcus aureus, is 
largely unknown. Therefore, the objective of this investigation was 
to examine the determinants which affect a-toxin production in 
Staphylococcus aureus and, through genetic analysis by transformation, to 
unambiguously assign these determinants a position on the chromosomal 
linkage map. 
An understanding of the genetics of a-toxin production is important 
not only from a theoretical standpoint but offers an excellent opportunity 
to construct strains which specifically produce this cytolytic toxin. 
These strains would then offer an opportunity to better define the role 
a-toxin plays as an agent of pathogenesis. Also, purified a-hemolysin 
derived from such strains could be used as a highly specific probe in 
the study of cell membranes. 
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LITERATURE REVIEW 
Cytolytic toxins of bacteria can be defined as extracellular products 
of bacterial growth that are of relatively large molecular size and that 
cause gross lysis dm vitro of one or more kinds of mammalian cells. 
Bernheimer (1970) states that this may be an imprecise definition because 
lysis may not be restricted to mammalian cells; in addition, the word 
lysis, denoting gross dissolution, is misleading because the degree of 
cellular disruption varies considerably with different kinds of cells. 
A better criterion of lysis (Bernheimer, 1970) would be loss of an ap­
preciable amount of cell substance accompanied by substantial loss of 
morphological and functional integrity. Alouf (1977) defines a bacterial 
cytolytic toxin as any toxic protein or polypeptide which upon reversible 
or irreversible binding to one or several components of the cytoplasmic 
membrane of any living animal, plant, or microbial cell, disorganizes 
the lipoprotein structure of the membrane, leading to a loss of morpho­
logical and functional integrity of the cell. 
It is also well-known that some cytolytic toxins are lethal in 
"relatively small amounts" for laboratory animals. Here again the 
definition of a "relatively small amount" is misleading since the minimum 
lethal dose of all cytolytic toxins is massive as compared to that of 
tetanus or botulinum toxin. Of the several toxic and potentially toxic 
products of pathogenic staphylococci, the most potent is the a-toxin 
(Arbuthnott, 1970). Staphylococcal a-toxin in intravenous doses of 
about one microgram is lethal for mice, whereas as much as a milligram 
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of either staphylococcal g- or ô-toxin may not be lethal. 
Bacterial cytolytic toxins are also distinguished from other toxic 
bacterial products, such as diphtheria toxin, tetanus toxin, staphylo­
coccal enterotoxins and many others which do not cause prompt gross lysis 
of cells. Bacterial cytolytic toxins can be divided into two groups: 
those that are SH-activated (thiol-activated) or oxygen labile and those 
that are SH-independent (Bernheimer, 1974; Alouf, 1977). Table 1 shows 
these two groups of cytolytic toxins. The SH-dependent toxins, of which 
streptolysin 0 is the prototype, are chemically and immunologically 
related (Alouf, 1977). The other cytolytic toxins, to which the staphylo­
coccal hemolysins belong, show no close relationship to each other. 
Staphylococci produce at least four hemolysins or cytolytic toxins: 
alpha (a), beta (3), delta (6), and gamma (y). The y-hemolysin was first 
described by Smith and Price in 1938; however, it has only recently gained 
acceptance as a separate toxin. The physiochemical characteristics of 
Y-hemolysin show that it consists of two components, both having an iso­
electric point (pi) of about 9.5 to 9.9 (Wadstrom and Mollby, 1972; 
Taylor and Bernheimer, 1974). y-hemolysin is a protein (Fackrell and 
Wiseman, 1976), whose activity is inhibited by agar and other acid polymers 
(Taylor and Bernheimer, 1974). Information relating to the toxicity 
and mode of action of y-hemolysin is at best fragmentary. Since y -
hemolysin is inhibited by agar and therefore was probably not a relevant 
factor in this study and also because of its relatively recent acceptance, 
it will not be discussed in detail in this review. 
Table 1. Bacterial cytolytic toxins^ 
Thiol-dependent cytolytic toxins Other cytolytic toxins 
Bacterium Toxin Bacterium Toxin 
Streptococcus pyogenes 
Streptococcus pneumoniae 
Bacillus cereus 
Bacillus thuringiensis 
Bacillus alvei 
Bacillus laterosporus 
Clostridium bifermentans 
Clostridium botulinum 
Clostridium histolyticum 
Clostridium novyi 
Clostridium perfringens 
Clostridium septicum 
Clostridium tetani 
Listeria monocytogenes 
Streptolysin 0 
Pneumolysin 
Careolysin 
Thuringiolysin 
Hemolysin 
Hemolysin 
Hemolysin 
Hemolysin 
e-toxin 
y-toxin 
0-toxin 
Hemolysin 
Tetanolysin 
Listeriolysin 
Streptococcus pyogenes 
Staphylococcus aureus 
Staphylococcus aureus 
Staphylococcus aureus 
Staphylococcus aureus 
Clostridium perfringens 
Escherichia coli 
Aeromonas hydrophila 
Streptolysin S 
a-toxin 
B-toxin 
6-toxin 
y-toxin 
a-toxin 
Hemolysin 
Hemolysin 
^Data taken from Alouf (1977). 
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The a-, g-, and 6-hemolysins of staphylococci have been studied 
extensively and are the subject of several recent reviews (Jeljaszewicz, 
1972; Bernheimer, 1974; Wiseman, 1975; Alouf, 1977). Even though 
this study deals primarily with the a-toxin of Staphylococcus aureus, 
it would indeed be difficult, if not impossible, to attempt interpreta­
tion of the results without regard to the and ô-toxins. Staphylococci 
may produce several cytolytic toxins simultaneously and each must be 
evaluated in relationship to the others. Therefore, the generally 
recognized physiochemical and biological characteristics of each of these 
toxins will be reviewed. In addition to the hemolytic exotoxins, 
staphylococci produce a large number of potentially toxic factors and 
enzymes, including staphylokinase or fibrinolysin, coagulase, thermo­
stable nuclease, lipase, and protease. Each of these will also be 
considered in regard to their association or interaction with the cyto­
lytic toxins. There is no doubt that the greatest difficulty in formu­
lating a working hypothesis for the mechanism of pathogenicity of 
staphylococci is the evaluation of the relative importance of this 
plurality of toxic products. 
Physiochemical and Biological Properties of 
Staphylococcal Cytolytic Toxins 
3-Toxin 
The 3-toxin of Staphylococcus aureus was first described as a 
separate hemolysin by Glenny and Stevens (1935). The most striking 
characteristic of this hemolysin is its capacity to produce "hot-cold" 
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hemolysis, referring to the enhanced hemolytic activity of this toxin if 
incubation at 37C is followed by incubation at 4C or room temperature. 
Its hemolytic activity is also greatly enhanced by Mg^^, Mn^^, or Co^^ 
ions and is inhibited by citrate, EDTA, ascorbic acid and cysteine 
(Jackson and Mayman, 1958; Wiseman, 1965a,b). Bernheimer (1974) refers to 
the ^-hemolysin as the cytolytic toxin par excellence since it is both an 
enzyme and a toxin, g-hemolysin is one of the few cytolytic toxins for 
which the exact mode of action is known (Doery et al., 1963; Doery et al., 
1955; Low and Freer, 1977a,b). Staphylococcal g-toxin is a phospho-
lipase C (sphingomyelinase C) specific for sphingomyelin and lysophosphatidyl 
choline (Low and Freer, 1977a). The hydrolysis of sphingomyelin is 
catalyzed as follows: 
sphingomyelin + water ^ toxin^ N-acylsphingosine + phosphorylcholine 
Bernheimer (1974) suggests that extensive hydrolysis of the phospholipid 
(sphingomyelin) of the outer leaflet of the erythrocyte membrane could 
leave areas that are essentially lipid monolayers. These regions main­
tain cell integrity at 37C, but lowering the temperature may be ac­
companied by thermodynamic instability leading to multiple areas of 
membrane collapse. Because of its known mode of action, g-toxin can 
serve as a highly specific probe of membrane structure. A relationship 
between sphingomyelin concentration and erythrocyte susceptibility to 
g-hemolysin has been established (Wiseman and Caird, 1967). 
The purification of g-toxin has been undertaken in many laboratories 
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(Wadstrom and Mollby, 1972; Bernheimer et al., 1974; Low and Freer, 1977b). 
Low and Freer (1977b) obtained a major peak of hemolytic activity at a pi 
of 9.3 which agreed closely with a pi of 9.0 obtained by Bernheimer 
et al. (1974). Both laboratories also found a minor peak of activity at 
a higher pH. It appeared that ^ -hemolysin does display some micro-
heterogeneity (Low and Freer, 1977b). The molecular weight was esti­
mated to be 33,000 (Low and Freer, 1977b) which closely agrees with 
previous results (Wadstrom and Mollby, 1971a; Bernheimer et al., 1974). 
The sedimentation coefficient of 3.IS obtained by Low and Freer is very 
close to that reported for a-hemolysin and could inhibit effective separa­
tion. However, Bernheimer et al. (1974) have shown that apparently pure 
preparations of the two toxins yield close but resolvable bands by SDS-
polyacrylamide gel electrophoresis. 
The sensitivity of various erythrocyte species to g-hemolysin is 
easily distinguished from either a- or 6-hemolysin (Table 2). As 
previously mentioned, 3-hemolytic activity is closely correlated with 
the sphingomyelin content of various erythrocyte species (Wiseman and 
Caird, 1967)• The erythrocytes of dog, guinea pig, and rabbit are 
almost totally resistant. Bernheimer et al. (1974) suggested that 
rabbit erythrocytes may be completely resistant and that reports of lysis 
of rabbit erythrocytes by 3-toxin are due to their sensitivity to a-
toxin. As little as 1% contamination (by weight) of g-toxin by a-
toxin could account for the sensitivity of rabbit erythrocytes. 
It is generally accepted that ^-hemolysin production is more 
Table 2. Relative sensitivity of erythrocytes from various mammalian species to staphylococcal 
cytolytic toxins 
Toxin Reference Sensitivity of erythrocytes compared to those of rabbit (%) 
(Hemolysin) Rabbit Sheep Horse Rat Swine Goat Cat Dog Guinea Mouse Human 
Pig 
a Bernheimer, 1974 100 1 0.6 10 ND^ 1 5 25 0.1 9 0.8 
B Bernheimer et al., 0.1 100 ND ND ND 20 ND 0.1 0.1 ND 0.5 
1974 
6 Kreger et al., 100 20 100 ND 20 10 10 ND 25 ND 50 
1971 
Y Wadstrom et al., 100 ND ND ND ND ND ND ND ND 0.1 
1974 
^Not determined. 
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prevalent among staphylococci of animal origin (Elek, 1959). The contri­
bution of 3-toxin to pathogenicity is still unknown. Low and Freer 
(1977a) studied the lethal and dermonecrotic effects of purified g-
hemolysin and found that intravenous injection (0.47 to 7.14 mg/kg body 
weight) in mice is nontoxic, and has no detrimental effect on weight 
increase. They also found that intradermal injections do not result in the 
formation of any lesion, nor is there any reddening of the skin. They 
felt that previous reports (Gow and Robinson, 1969; Wadstrom and Mollby, 
1971b) of ^ -hemolysin toxicity should be re-examined. The presence of 
low (perhaps sub-hemolytic) levels of a- or 6-hemolysin, acting inde­
pendently or synergistically, could account for the toxic effects observed. 
3-hemolysin may have a role in pathogenicity by acting to increase the 
sensitivity of normally resistant cells to attack by other extracellular 
products of staphylococci, for example, a- and 6-hemolysins (Mollby 
et al., 1974). 
6-Toxin 
Williams and Harper (1947) were the first to propose the existence of 
6-hemolysin in staphylococci. They observed that the hemolytic activity 
of certain strains of Staphylococcus aureus was not suppressed in the 
presence of a- and $-antitoxins. The ô-hemolysin has a wider spectrum of 
hemolysis (Table 2) than a- and g-hemolysins, acting on erythrocytes of 
rabbit, sheep, human, horse, and guinea pig. Marks and Vaughan (1950) con­
firmed the existence of 6-toxin and found that it acted synergistically with 
3-toxin on human and sheep erythrocytes. Bernheimer (1974) discussed 
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staphylococcal ô-hemolysin and the surfactin of Bacillus subtilus as 
examples of cytolytic microbial products that are substantially different 
in character, and probably in mode of action, from most cytolytic 
bacterial toxins. Their behavior tends to resemble that of detergents. 
Yoshida (1963) first reported purification of ô-toxin to the 
crystalline state; however, subsequent attempts at crystallization have 
been unsuccessful. Heatley (1971), Kreger et al. (1971), and Kantor et al. 
(1972) purified ô-hemolysin and found that it is a protein from which 
histidine, arginine, proline, tyrosine, and cysteine are absent. Kreger 
et al. (1971) stated that an analysis of highly purified soluble 6-
hemolysin by density gradient centrifugation, gel filtration, analytical 
ultracentrifugation, carboxymethyl cellulose chromatography, poly-
acrylamide disc gel electrophoresis, isoelectric focusing, and electron 
microscopy revealed that the lysin is molecularly heterogenous. Their 
preparation contained an acidic fibrous lysin with a sedimentation 
coefficient of 11.9S and a basic lysin composed of granular aggregates of 
various sizes, with a maximum ^ value of 4.9. Isoelectric focusing 
yielded two distinct ô-hemolysin peaks, both of which were inhibited 
by lecithin and rabbit serum. The main peak had a pi of approximately 
9.5 (representing 70% of the hemolytic activity) and the remaining 
activity focused at pi 5.0. Kantor et al. (1972) found three active 
hemolytic peaks at pi 4.65, 6.7, and 9.0. Each peak contained 30% of the 
activity of prefocused hemolysin. They found, however, that in the 
presence of 0.1% Tween 80 only a single active peak of pi 5.2 formed. It 
was suggested that a rather unprecedented degree of aggregation and 
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charge masking may have occurred in the presence of the nonionic deter­
gent. Wiseman (1975) concluded that the major proportion of ô-hemolysin 
activity is probably in the pi range of 9 to 10, 
Staphylococcal ô-hemolysin is differentiated from other staphylo­
coccal hemolysins by its ability to lyse human and horse erythrocytes 
(Marks and Vaughan, 1950), its inhibition by phospholipids (Kreger et al., 
1971), and also by the fact that it is inhibited by dilute normal sera 
(Kreger et al., 1971; Maniar et al,, 1967; Wiseman and Caird, 1968). 
Kapral (1972) felt that the phospholipid content of sera or crude protein 
fractions may account for the inhibition of ô-hemolysin by normal sera. 
5-hemolysin is also differentiated from g- and a-hemolysins by its rela­
tive thermostability, its high surface activity and apparent nonanti-
genicity. Ô-hemolysin shows a low specific hemolytic activity, as compared 
to a- or g-hemolysin, which relates to its similarity to surfactants 
(Bernheimer, 1970). ô-toxin appears to be a surfactant polypeptide with a 
wide spectrum of activity. It has been shown to disrupt bacterial proto­
plasts and spheroplasts (Bernheimer et al,, 1968), tissue culture cells 
(Gladstone and Yoshida, 1967), leukocytes (Hallander and Bengtsson, 
1967), lysosomes (Evans and Lack, 1969), lipid spherules (Freer et al,, 
1968) and erythrocyte membranes (Hallander, 1968), In view of the 
broad spectrum of activity for ô-toxin, many previous studies regarding 
the biological effects of a-toxin must be reassessed, since a-toxin is 
often contaminated with ô-toxin (Bernheimer, 1974). 
13 
g-Toxin 
Among the growth products thought to contribute to virulence of the 
microorganism, staphylococcal a-toxin has been viewed as the most 
important (Arbuthnott, 1970; Bernheimer, 1974). This toxin is synthe­
sized intracellularly and is released continuously into the surrounding 
medium, the process being very sensitive to alkalinization (Hendricks 
and Altenbern, 1968) . Despite the fact that a-toxin was the first 
recognized and probably most extensively studied staphylococcal cytolytic 
toxin (Elek, 1959), the nature of its substrate or receptor site in cell 
membranes and its true role in the pathogenesis of human disease remain 
undefined. 
The hemolytic spectrum of a-toxin against various erythrocyte 
species (Table 1) is easily distinguished from 3-hemolysin. ô-hemolysin 
is reactive against many of the same erythrocyte species as a-hemolysin; 
however, its spectrum of activity is much broader and it is apparently 
less specific. Forlani et al. (1971) and Six and Harshman (1973b) have 
reported a sedimentation coefficient of 2.8 to 3.IS which is in agreement 
with values of about 3.0 reported earlier (Bernheimer and Schwartz, 1953; 
Lominski et al-, 1963; Coulter, 1966; Cooper et al., 1966). Estimates 
of molecular weight obtained by sedimentation and diffusion studies are 
26,000 to 29,000 (Forlani et al., 1971) and 26,000 to 31,000 (Six and 
Harshman, 1973b). Six and Harshman (1973b) also reported a molecular 
weight of 27,500 by SDS-gel electrophoresis and by summation of amino 
acid analysis obtained molecular weights of 26,500 and 28,500 for the two 
forms (A and B respectively) of a-toxin they isolated. Purified a-toxin 
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has been found repeatedly to be electrophoretically heterogeneous (Bern-
he imer and Schwartz, 1953; Wadstrom, 1968; McNiven et al., 1972); how­
ever, the several (up to four) electrophoretic varieties appear to be 
similar, if not identical, immunologically and in their biological 
effects. Six and Harshman (1973a,b) found two electrophoretically 
distinguishable, noninterconvertible forms of a-toxin (forms A and B) which 
occurred in a specific ratio. They considered them to be "charge isomers" 
rather than size isomers of one another. Wiseman (1975) suggested that 
variations in the N-terminal amino acids and molecular weights of 
various a-toxin preparations could be caused by proteolytic activity in 
crude preparations. 
Another form of a-toxin having a sedimentation coefficient of ap­
proximately 12S apparently forms spontaneously from 3S a-toxin (Bern-
heimer, 1974). This view is supported by the observation of Arbuthnott 
et al. (1967) that 12S hemolysin is disaggregated by urea to yield active 
3S hemolysin. These investigators also reported that in Ouchterlony 
double diffusion tests the purified 12S material gives a line of partial 
identity with the main a-toxin line of precipitation. Six and Harshman 
(1973b) reported that forms A and B of a-toxin contained a small amount 
(8%) of material with a sedimentation coefficient of 10.9S after 
standing. They assumed that this material corresponds to the 12S inactive 
hexamer previously reported (Bernheimer and Schwartz, 1963; Lominski 
et al., 1963). Therefore, it is now believed that the 12S form represents 
a hexamer of the more active 3S form of a-toxin (Freer et al., 1968; 
Bernheimer, 1974). The formation of 12S a-toxin might also explain the 
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well-known "Arrhenius effect" (Elek, 1959) where a-hemolysin is in­
activated at 60C and reactivated by brief heating at lOOC. Wiseman 
(1975) suggests that heating at 60C causes aggregation of the active 
3S component and that further heating to lOOC or treatment with urea 
disaggregates the insoluble 12S component. 
The mode of action of staphylococcal a-toxin and, as a consequence, 
its interaction with the cell membrane, is not yet fully understood. 
Most investigators consider the cell membrane to be the primary site 
of a-toxin activity (Wiseman, 1975). However, there are reports of a-
toxin affecting ion transport (Rahal et al., 1967), decreasing adenosine 
5'-triphosphate levels in tissue cultures (Galanti et al., 1968), abolish­
ing phosphorylation of adenosine 5'-diphosphate in mitochondria (Novak 
et al., 1971) and causing the lysis of bacterial spheroplasts (Bern-
heimer and Schwartz, 1965) and mycoplasma (Bernheimer and Davidson, 
1965). Cassidy et al. (1974) have reported that a-hemolysin has no 
2+ + + 
effect on Ca or (Na ,K ) dependent membrane adenosine triphosphatase, 
proton translocation in mitochondria, or the integrity of membranes of 
Mycoplasma. These investigators and others have suggested that previous 
reports of a-toxin activity against a variety of animal and bacterial 
cell membranes should be reassessed in view of the possibility of con­
taminating 5-hemolysin. 
The mechanism by which a-hemolysin selectively lyses various 
species of erythrocytes is unknown. There are presently two lines of 
thinking which in essence are probably not mutually exclusive. Freer 
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et al. (1973) suggest that a-toxin has a relatively high surfare activity 
and that it is capable of hydrophobic interaction with lipids. Buckelew 
and Colacicco (1971) and Colacicco and Buckelew (1971) found that a-
toxin readily forms a film on aqueous media and that it is capable of 
penetrating lipid monolayers. These results suggest that a-toxin 
interacts with, and subsequently disrupts, the membrane through a "sur­
face active" principle. Bernheimer (1974) questions the validity of these 
conclusions because purified a-toxin is often contaminated with 6-toxin 
which is a highly surface active agent. Cassidy et al. (1974) reported 
that purified a-toxin can interact with lipid spherules (liposomes) 
composed of lecithin, cholesterol, and dicetyl phosphate and with lipo­
somes composed of lipid extracted from erythrocyte membranes. This inter­
action was measured by the release of both low and high molecular weight 
markers. However, despite the known 100-fold difference in sensitivity 
to a-toxin of rabbit erythrocytes as compared to human erythrocytes, no 
difference in sensitivity to the toxin was observed between liposomes 
composed of lipids extracted from rabbit or human blood cells. 
The other view of the mode of action of a-hemolysin has been put 
forward by Wiseman and Caird (1970, 1972) and Wiseman et al. (1975). 
These investigators suggest that a-toxin is secreted by the Staphylococcus 
as an inactive protease which must be activated by an erythrocyte 
protease. The degree of activity of the protease in various red cell 
species would explain their differential sensitivity to a-toxin. They 
found that although a-toxin released no acid-soluble phosphorus from 
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rabbit erythrocyte membranes, nitrogen appeared in the supernatant fluid 
and increased proportionally with respect to time (Wiseman and Cai'rd,1970). 
This same phenomenon was observed with lipid-free rabbit erythrocyte mem­
brane protein. Freer et al. (1973) were unable to confirm evidence of a pro­
teolytic mechanism in the mode of action of a-hemolysin. Therefore, there 
remain two views of the interaction of a-hemolysin with the erythrocyte 
membrane, one involving a surface active interaction with the erythrocyte 
lipids and the other involving an activation of pro-a-toxin to active toxin 
by an erythrocyte proteinase. Moore et al. (1970) found that erythrocyte 
proteinase activity is associated with membrane lipoprotein. Therefore, 
as suggested by Wiseman (1975), it is possible that the interaction of a-
hemolysin with membrane lipoproteins might anchor it in a particular con­
formation which is susceptible to the action of proteinase activator. 
The toxicity of a-hemolysin to both warm- and cold-blooded animals is 
well-documented (Wiseman, 1975). Fackrell and Wiseman (1976) have re­
ported that the mean lethal dose (LD^^) in mice injected intra-
peritoneally is 27 to 34 yg per kilogram body weight. Arbuthnott (1970) 
has found that the hemolysin acts on the peripheral circulation, heart, 
and central nervous system, a-toxin is partially defined then by; (1) 
its capacity to lyse rabbit erythrocytes, (2) its cytotoxicity for a 
variety of cultured mammalian cells, and (3) its lethality for laboratory 
animals. 
An overall assessment of the biological and physiochemical properties 
of the staphylococcal cytolytic toxins indicates that they are a group of 
individually and collectively heterogeneous proteins. With the exception 
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of 3-hemolysin, the exact mode of action of these toxins remains largely 
unknown. It is generally accepted that none of the extracellular 
products that are characteristic of pathogenic staphylococci has been 
shown unequivocally to be a major determinant of infection and disease. 
The possible interaction of these cytolytic toxins with each other and 
also with other extracellular enzymes and toxins undoubtedly contributes 
to the overall economy and pathogenesis of the cells that produce 
them. Therefore, it is impossible to view the role of any one of them 
in isolation. In addition to the importance of cytolytic toxins in 
pathogenesis, some exhibit remarkable specificity. Because of this 
specificity, a better understanding of their nature and function may 
prove very useful in the general study of cell membranes. 3-hemolysin 
has already been shown to serve as a highly specific probe of membrane 
structure (Low and Freer, 1977a). 
Genetics of Staphylococcus aureus 
The genetic analysis of Staphylococcus aureus was initiated with the 
demonstration of generalized transduction in this bacterium (Morse, 
1959). This technique has served as a useful tool for the "fine structure" 
genetic analysis of specific regions of the staphylococcal chromosome 
(as reviewed by Egan, 1972) and also the genetic characterization of 
plasmids (Lacey, 1975). However, because of the limited size (Lacey, 
1975) and apparent homogeneity (Pattee et al., 1968) of the transducing 
fragments, generalized transduction is only of limited value in studying 
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the gross organization of the staphylococcal chromosome. 
In 1972, Lindberg et al. discovered transformation in Staphylococcus 
aureus strain 8325. Staphylococcus aureus was rendered competent to bind 
and take up genetically active DNA by exposure to a relatively high con­
centration (0.1 M) of CaClg. It was found that the recipient culture must 
•be lysogenic for either phage J311 or 83A in order for competence to be 
expressed (Sjostrom et al., 1973; Sjostrom and Philipson, 1974). 
Competence-conferring activity was attributed to an early gene product of 
the phages. Subsequent studies (Thompson and Pattee, 1977; Martin et al., 
1978; Shoham et al., 1978) have shown that virtually all coagulase-
positive staphylococci are amenable to transformation and also all Group 
B phage can confer competence on Staphylococcus aureus. It is currently 
held that the phage-host interaction leading to competence involves 
interaction of the phage attachment organelle or some component of this 
organelle with the cell surface leading to the binding and entry of the 
DNA (Thompson and Pattee, 1977). 
Transformation has been shown to be a useful method for studying the 
gross organization of the staphylococcal chromosome (Pattee and Neveln, 
1975; Pattee, 1976; Pattee et al., 1977) and also the study of plasmid 
linked markers (Lindberg et al., 1972; Lindberg and Novick, 1973; Stiffler 
et al., 1974). Unfortunately, the use of transduction or transformation 
for the study of the staphylococcal cytolytic toxins and other extracellu­
lar products has been very limited. A major obstacle to such studies is 
the fact that these extracellular products are not essential to the 
in vitro survival of staphylococci. Therefore, the acquisition of the 
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capacity to produce a-hemolysin, for example, by a nonhemolytic recipient 
population is not selectable using current techniques. Previous 
studies of these unselectable traits, therefore, suffer in reliability 
since only a very small number of recombinant cells is observed among an 
enormous nonrecombinant population. In many cases, the reversion frequency 
was not significantly lower than the transduction frequency. Reliable 
genetic analysis of the production of these extracellular products by 
staphylococci necessitates the discovery of selectable genetic markers 
which are cotransferable with them; the unselected phenotype can then 
be scored among the recombinants so obtained. 
The current status of research dealing with the genetics of staphylo­
coccal cytolytic toxins and their possible association with other extra­
cellular virulence factors is very fragmentary. The a-, 3, and 6-
hemolysins have each been shown to be produced, or not produced, as a 
result of phage conversion. In some cases their production has been 
associated with extrachromosomal elements and in other cases with the 
chromosome. Several studies have also shown the pleiotropic alteration 
of several virulence factors after treatment with mutagenic agents. 
Genetics of the Staphylococcal 
Cytolytic Toxins 
Blair and Carr (1961) lysogenized strains of Staphylococcus aureus 
which exhibited phage-type patterns of the 80/81-52/52A/80/81 complex 
with a phage designated L2043. This phage had been obtained from broth 
filtrates of strain 2043. After lysogenization, three recipient strains 
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displayed a change in phage-type which was characteristic of strain 2043. 
In addition, two of the three recipients displayed an increase in a-
hemolysin production to a level comparable to strain 2043, suggesting 
that a-hemolysin production might therefore be associated with phage 
conversion. 
Lysogenic conversion of staphylococci to loss of 3-toxin has been 
reported (Winkler et al., 1965). Strains producing g-hemolysin and 
lacking staphylokinase (fibrinolysin) activity were converted by lyso-
genization to loss of g-toxin and gain of staphylokinase. They stated that 
conversion is due to two separate loci on the phage which are active in the 
prophage state. However, they also reported that the genes responsible for 
3-hemolysin and fibrinolysin production in some strains of Staphylococcus 
aureus must be chromosomal, since these extracellular products are not 
always associated with the presence of prophage. The authors further 
suggested that the 3-toxin locus may be a regulator gene that is suppressed 
in the presence of certain prophage. 
The capacity of staphylococci to produce 6-toxin has been associated 
with converting phage (Clecner and Sonea, 1966). These investigators 
lysogenized three strains of Staphylococcus aureus with temperate phages 
obtained from strains producing ô-hemolysin. The recipient strains, 
in addition to becoming lysogenic for the infecting phage, acquired the 
capacity to produce 6-hemolysin. When the recipient strains were cured 
of these prophages with acridines, they also lost the capacity to 
produce 5-hemolysin. 
Harmon and Baldwin (1964) isolated thirty-one penicillin-sensitive 
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mutants of Staphylococcus aureus strain U9W using UV-irradiation and chemi­
cal mutagens. One of the thirty-one penicillin-sensitive mutants failed to 
produce detectable amounts of a-hemolysin, lipase, fibrinolysin, gela-
tinase, and caseinase> while it retained normal nuclease, coagulase, and 
3-hemolysin activities. This report suggested that pleiotropic loss of 
multiple genetic characters, including toxin production, could be induced 
in Staphylococcus aureus. Later, Forsgren et al. (1971) exposed 
Staphylococcus aureus strain Cowen I to N-methyl-N'-nitro-N-nitroso-
guanidine (NG) and ethylmethane-sulfonate (EMS) and found that more 
than half of all protein A-deficient mutants also lacked nuclease, 
coagulase, a-hemolysin, and fibrinolysin activities. The mutants also 
exhibited a change in phage-type and were unable to ferment mannitol. In 
almost all cases there appeared to be a correlation between reduction or 
elimination of a-hemolysin activity and protein A production. More than a 
third of all mutants obtained with NG were negative for all activities. 
The return of these properties in reversion experiments suggested a com­
mon control mechanism; however, in many instances, one or two properties 
were not regained. Omenn and Freidman (1970) reported mutants of 
Staphylococcus aureus which had a combined loss of nuclease, coagulase, 
and 3-hemolysin. In reversion experiments all three enzyme functions 
were regained together, a-hemolysin activity was normal in all of the 
mutants. On the basis of heat elimination experiments, it was shown 
that nuclease-deficient mutants did not result from plasmid elimination. 
They suggested that the synthesis or release of certain extracellular 
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enzymes may be subject to coordinated control mechanisms. Yoshikawa et al. 
(1974) also reported pleiotropic alteration of several toxins and enzymes 
in mutants of Staphylococcus aureus obtained by NG mutagenesis. However, 
they found that a-hemolysin hyperproducers were also hyperproducers of 
nuclease, coagulase, and protease. The mutant colonies were found to be 
less yellow than the wild type. Hyperproduction of the various products 
was not associated with increased growth rate. 
Lacey and Chopra (1975) studied strains 649N, 649MR, and 549MR-N of 
Staphylococcus aureus for the association of several plasmids with pro­
duction of a-, 3-, and ô-hemolysins, coagulase, fibrinolysin, nuclease, 
and lipase. They found that the loss of seven plasmids from strain 649MR 
(= strain 649MR-N) had no effect on the production of these extracellular 
products. Furthermore, the colonial morphology, pigmentation, and phage-
typing patterns of the strains were similar- Strain 8325 of Staphylococcus 
aureus has been found to be a plasmid-free strain (Novick, 1967); how­
ever, it produces several hemolysins, nuclease, coagulase, fibrinolysin, 
lipase, gelatinase, and other extracellular products. 
Wheeler (1975) examined a large number of colonies of Staphylococcus 
aureus by replica-plating and found that a-hemolysin and fibrinolysin were 
lost simultaneously after UV-irradiation. No evidence of a plasmid locus 
for the a-hemolysin gene(s) was found. McClatchy and Rosenblum (1966a,b) 
also reported an association of a-hemolysin production with fibrinolysin 
(staph/iokinase) activity. They obtained twenty nonhemolytic mutants of 
Staphylococcus aureus strain 233 by UV-irradiation and treatment with 
nitrous acid. In addition to lacking a-hemolysin activity, eleven of the 
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twenty mutants also failed to produce fibrinolysin. On the basis of two-
point reciprocal transductions the mutants were placed into two genetic 
groups. The mutants of one group were postulated to be a-toxin structural 
mutants whereas those of the second group presumably resulted from muta­
tional lesions in a pleiotropic gene simultaneously affecting synthesis 
of both a-toxin and fibrinolysin. 
There has been only one report dealing with the transformation of 
cytolytic toxins in Staphylococcus aureus. Nomura et al. (1971) reported 
that they were able to effect transformation of g- and ô-hemolysins into 
nonhemolytic strains of Staphylococcus aureus. However, they did not 
report transformation of other markers, and subsequent reports on this 
system have not appeared. Therefore, even though their results are 
interesting in light of this investigation, they must be viewed with some 
skepticism. 
There is obviously no unifying concept of the genetic mechanisms in­
volved in cytolytic toxin production in Staphylococcus aureus. The a-
3-/ and ô-hemolysins have each been shown to be associated with converting 
phages- There is also considerable evidence showing pleiotropic alteration 
of toxin production with other extracellular products. Yoshikawa et al. 
(1974) suggest the possibility that these characters are controlled by a 
common regulatory mechanism, including involvement of plasmids, for 
synthesis or release of these exoenzymes. If the structural genes for 
these multiple characters are under the control of a single repressor, or 
if there is an active release mechanism common to all of them, then their 
activities could be pleiotropically altered. Yet, this does not explain 
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the reported variations in pleiotropic association among these extra­
cellular products. It is possible that genetic control of the production 
of these extracellular products differs among individual strains of 
staphylococci. This does not seem likely if one considers the inefficiency 
of such genetic diversity for the overall economy of this organism. Varia­
tions in the pleiotropic association of specific cytolytic toxins with 
other extracellular products might also result from improper identification 
of the hemolysins. 
There is no doubt that the genetics of cytolytic toxin production in 
staphylococci remains in its relative infancy. However, with the recent 
discovery of transformation in this organism and the elucidation of chromo­
somal linkage groups in Staphylococcus aureus these mechanisms are now 
amenable to genetic analysis. Information derived from such studies is 
invaluable not only to understanding the genetic complexity of Staphylo­
coccus aureus but also to further elucidate the physiochemical and 
biological properties of these toxins. 
26 
MATERIAL AND METHODS 
Bacteria and Bacteriophages 
The cultures of Staphylococcus aureus used in this study are listed in 
Table 3, along with their genotypes and origins. Some of these strains 
carry translocation elements; these elements are indicated by a Greek 
omega (fi) followed by a serial isolation number and then by information 
about the insertion in brackets. For example, strain ISP 197 (Table 3) 
is designated 8325-fl7[Chr; :Tn551], indicating that this strain contains 
the translocon (Tn) 551 and that this translocon is inserted into the 
chromosome (Chr). Tn551 is the erythromycin-resistance determinant of 
plasmid pl258 in Staphylococcus aureus and this element is capable of 
translocation to at least eight different chromosomal sites (Novick 
et al., 1978). Therefore, the omega (i.e., fi7) designation not only 
refers to the original serial isolation number but also serves to identify 
its chromosomal map location, if known. All cultures were maintained on 
brain heart infusion (BHI, Difco) agar slants supplemented with thymine, 
purines, and pyrimidines and stored at 4C. The Staphylococcus reference 
typing phages and their propagating strains were obtained from the Center 
for Disease Control (CDC), Atlanta, Georgia. Phage 80a was obtained 
from F. E. Young (University of Rochester, Rochester, New York). Phages 
011 and 012 were obtained from N. E. Thompson as single-plaque isolates 
from strains 8325-4(011) and 8325-4(012) as described by Thompson and 
Pattee (1977). All phages were maintained in trypticase soy broth 
(TSB, BBL) and stored at 4C. 
Table 3. Designation, genotype, and origin of strains of Staphylococcus aureus 
Strain Genotype Origin Reference 
ISP 1 8325thy-101,pig-131 Single clone of 8325thy Lindberg et al., 1972. 
Pattee and Neveln, 1975. 
ISP 2 8325nov-142,pig-131,hla-156 ISP 17 X ISP 11 DNA Pattes and Neveln, 1975. 
ISP 4 8325thy-101,thrBlOô,pig-•131 ISP 1 X NG Pattee and Neveln, 1975. 
ISP 5 8325thy-101,thrBloe,ilv-
pig-131 
129, ISP 4 X NG Pattee and Neveln, 1975. 
ISP 8 8325-4pig-131,hla-163 Novick Novick, 1957. 
ISP 11 8325(pI258),piq-131 Lindberg Pattee and Neveln, 1975. 
ISP 17 8325thy-101,nov-142,pig-•131 ISP 1 X ISP 211 DNA Pattee and Neveln, 1975. 
ISP 39 8325thy-101,pur-102,pig--131 ISP 1 X NG Pattee and Neveln, 1975. 
ISP 44 8325thy-101,pur-110,pig-•131 ISP 1 X NG Pattee and Neveln, 1975. 
ISP 93 Ps5tmn-3110,hla-162 Ashehov Ashehov, 1975. Pattee, 1976. 
Pattee et al., 1977. 
ISP 94 Ps6tmn-3511,hla-162 Asheshov Ashehov, 1975. Pattee, 1976. 
ISP 99 8325thy-101,pur-110,tmn-
piq-131 
-3106, ISP 44 X ISP ' 92 DNA This laboratory 
ISP 100 DU4916mec-4196 Sjostrom Kuhl, Pattee, and Baldwin, 1978 
ISP 103 8325thv-101,thrB106,ilv-
tinn-3106,pig-131 
-129, ISP 5 X ISP 92 DNA This laboratory 
Table 3 (Continued) 
strain Genotype Origin 
ISP 161 
ISP 163 
ISP 167 
ISP 171 
ISP 194 
ISP 195 
ISP 196 
8325nov-142,tnin-3106,pig-131 ISP 2 X 085/ISP 92 
hla-156 
8325nov-142,tnin-3106,bla"^, ISP 161 X 053/ISP 230 
pig-131,hla-156 
8325-4^1[Chr;;Tn551],piq-131 RN872; Novick 
hla-163 
8325-401 [Chr;;Tn551] ,tinn-
3106, hla-163 
8325-3mil[Chr::Tn551] 
8325Ml2[Chr:îTn551] 
8325-4fi5[Chr::Tn551] 
ISP 167 X 085/ISP 92 
RN32; Novick 
RN33; Novick 
RN496; Novick 
ISP 197 8325-407[Chr;;Tn551I 
ISP 211 655nov-142 
RN497; Novick 
ISP 227 Ps6hla-162 
ISP 230 Ps53bla 
ISP 263 8325-3011[Chr;;Tn551],tmn-
3106 
ISP 264 8325012[pI258ermB],tmn-
3106 
C.D.C. 
C.D.C. 
ISP 194 X j380a/ISP 161 
ISP 196 X 08Oa/ISP 161 
Reference 
Pattee et al., 1977. 
This laboratory 
Novick, 1967. 
Pattee et al., 1977. 
Pattee et al., 1977. 
Novick, 1967. 
Novick, 1967. 
Novick, 1967. 
Pattee et al., 1977. 
Novick, 1967. 
Pattee et al., 1968. 
Pattee and Neveln, 1975. 
This laboratory 
Pattee et al., 1977. 
This laboratory 
This laboratory 
Table 3 (Continued) 
Strain Genotype Origin 
ISP 265 8325-4fl5[Chr::Tn551],tmn-
3106, hla-163 
ISP 276 8325-3^11[Chr;;Tn551],tmn-
3106,nov-142 
ISP 278 8325012[pI258ermB],tmn-
3106,nov-142 
ISP 281 DU4916mec-4916,nov-142 
ISP 283 8325-405[Chr;;Tn551],tmn-
3106,nov-142, 
hla-163 
ISP 297 8325(80a)031[Chr;;Tn551] 
ISP 298 8325(80a)032[Chr;:Tn551] 
ISP 300 8325(80a)034[Chr::Tn551] 
ISP 304 8325(80a)038[Chr;;Tn551] 
ISP 314 8325(80a)031[Chr;;Tn551], 
tmn-3106 
ISP 315 8325(80a)032[Chr;;Tn551], 
tmn-3106 
ISP 317 8325(80a)034[Chr;:Tn551], 
tmn-3106 
ISP 196 X 08Oa/ISP 161 
ISP 263 X 08Oa/ISP 161 
ISP 264 X 08Oa/ISP 161 
ISP 100 X 08Oa/ISP 161 
ISP 265 X 08Oa/ISP 161 
RN2570; Novick 
RN2571; Novick 
RN2573; Novick 
RN2577; Novick 
ISP 297 X 08Oa/ISP 161 
ISP 298 X 08Oa/ISP 161 
ISP 300 X 08Oa/ISP 161 
Reference 
Pattee et al., 1977. 
This laboratory 
This laboratory 
Kuhl, Pattee, Baldwin, 1978. 
Pattee et al., 1977. 
to 
vo 
Novick, 1967. 
Novick, 1967. 
Novick, 1967. 
Novick, 1967. 
This laboratory 
This laboratory 
This laboratory 
Table 3 (Continued) 
Strain Genotype Origin 
ISP 321 
ISP 328 
ISP 329 
ISP 331 
ISP 335 
ISP 369 
ISP 370 
ISP 373 
ISP 380 
ISP 383 
ISP 386 
ISP 425 
ISP 426 
8325(80a)fi38[Chr:;Tn551], 
tmn-3106 
8325(80a)031[Chr:;Tn551], 
tmn-3106,nov-142 
8325(80a)fi32[Chr;;Tn551], 
tmn-3106,nov-142 
8325(80a)fi34[Chr:;Tn551], 
tiRn-3106, nov-142 
8325(80a)038[Chr: :Tn551], 
tmn-3106,nov-142 
8325045[Chr: :TnSSl] 
8325046[Chr::Tn551] 
8325049[Chr:;TnSSl] 
8325046[Chr: :TnSSl], 
tJtin-3106, hla-164 
8325049[Chr::TnSSl], 
tmn-3106,hla-165 
8325thy-101,mec-4916 
8325nov-142,piq-131,07 
[Chr::TnSSl] 
8325nov-142,piq-131,07 
[Chr:;Tn551], hla-156 
ISP 304 X 08Oa/ISP 161 
ISP 314 X 08Oa/ISP 161 
ISP 315 X 08Oa/ISP 161 
ISP 317 X j380a/ISP 161 
ISP 321 X 08Oa/ISP 161 
RN1860; Novick 
RN1861; Novick 
RN1864; Novick 
ISP 370 X 08Oa/ISP 161 
ISP 373 X 08Oa/ISP 161 
ISP 39 X ISP 281 DNA 
ISP 2 X ISP 197 DNA 
ISP 2 X ISP 197 DNA 
Reference 
This laboratory 
This laboratory 
This laboratory 
This laboratory 
This laboratory 
w 
Novick, 1967. 
Novick, 1967. 
Novick, 1967. 
This laboratory 
This laboratory 
Kuhl, Pattee, and Baldwin, 1978. 
This study 
This study 
Table 3 (Continued) 
Strain Genotype Origin Reference 
ISP 427 8325nov-142,pig-131/f231 
[Chr::Tn551],hla-156 
ISP 2 X ISP 328 DMA This study 
ISP 428 8325nov-142,pig-131,fi31 
[Chr::Tn551] 
ISP 2 X ISP 328 DNA This study 
ISP 429 8325nov-142,piq-l31,tmn-3106 ISP 2 X ISP 276 DNA This study 
ISP 430 8325nov-142,piq-131,tmn-3106 ISP 2 X ISP 276 DNA This study 
ISP 431 8325nov-142,piq-131, tmn-3106 ISP 2 X ISP 278 DNA This study 
ISP 432 8325nov-142,piq-131,tmn-3106 ISP 2 X ISP 278 DNA This study 
ISP 433 8325nov-142,pig-131,hla-
tinn-3106, pur-110 
•156, ISP 2 X ISP 99 DNA This study 
ISP 434 8325nov-142,pig-131,hla-
tmn-3106,pur-110 
•156, ISP 2 X ISP 99 DNA This study 
ISP 435 8325nov-142,pig-131,hla-
tmn-3106,pur-110,07 
[Chr:;Tn551] 
•156, ISP 433 X j380a/ISP 197 This study 
ISP 436 83 25nov-142,pig-131,hla-
tinn-3106, pur-110,07 
[Chr;:Tn551] 
•156, ISP 433 X 08Oa/ISP 197 This study 
ISP 437 83 25nov-14 2,pig-131,hla-
tmn-3105,pur-110,07 
•156, ISP 434 X jaaoa/isp 197 This study 
[Chr:;Tn551] 
Table 3 (Continued) 
Strain Genotype Origin Reference 
ISP 438 8325thy-101,thrB106,ilv-129, 
pig-131,07[Chr: :Tn551] 
ISP 5 X j380a/ISP 197 This study 
ISP 439 8325thy-101,thrB106,ilv-129, 
piq-131,^7[Chr::Tn551] 
ISP 5 X 08Oa/ISP 197 This study 
ISP 440 8325thy-101,thrB105, ilv-129, 
pig-131,07[Chr;:Tn551] 
ISP 5 X 08Oa/ISP 197 This study 
ISP 441 233hla-152,07[Chr::Tn551] ISP 462 X ISP 438 DNA This study 
ISP 442 233hla-152,07[Chr;:Tn551] ISP 462 X ISP 438 DNA This study 
ISP 443 23307[Chr:;Tn551] ISP 462 X ISP 438 DNA This study 
ISP 444 23307[Chr;;Tn551] ISP 462 X ISP 438 DNA This study 
ISP 445 8325(BOa)034[Chr;;Tn551], 
tinn-3105, nov-142 
Single ^-hemolysin 
producing clone of ISP 331 
This study 
ISP 446 8325thy-101,thrB106,ilv-129, 
piq-131,pur-110, 
07[Chr;:Tn551] 
ISP 5 X ISP 436 DNA This study 
ISP 447 8325thv-101,thrBlD6, ilv-129, 
pur-110,07[Chr::Tn551] 
Pig"*" revertant of ISP 446 This study 
ISP 448 832 5thy-101,thrB106,ilv-129, 
piq-131,pur-110, 
tmn-3106 
ISP 446 X ISP 103 DNA This study 
ISP 449 8325thy-101,thrB106,'ilv-129, 
piq-131,pur-110, 
tmn-3106 
ISP 446 X ISP 103 DNA This study 
Table 3 (Continued) 
Strain Genotype Origin Reference 
ISP 450 8325thy-101,thrB106,ilv-129, 
pur-110,07[Chr: :TnSSl] 
ISP 460 233hla-150 
ISP 461 233hlar-151 
ISP 462 233hla.-152 
ISP 463 233hla.-153 
ISP 464 233hla.-154 
ISP 465 233 
Pig revertant of ISP 
446 
Rosenblum (140c) 
Rosenblum (152a) 
Rosenblum (152d) 
Rosenblum (152i) 
Rosenblum (140a) 
Rosenblum 
This study 
McCiatchy and Rosenblum, 
1966b 
McCiatchy and Rosenblum, 
1966b 
McCiatchy and Rosenblum, 
1966b 
McCiatchy and Rosenblum, 
1966b 
McCiatchy and Rosenblum, 
1966b 
McCiatchy and Rosenblum, 
1966b 
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Culture Media 
All commercially available dehydrated culture media were supplemented 
with thymine (20 yg/ml) and adenine, guanine, cytosine, and uracil (5 yg of 
each per ml). Complete Defined Synthetic (CDS) agar (Table 4) has been 
described by Pattee and Neveln (1975) . Appropriate additions to, or 
deletions from, CDS agar were made to prepare the various selective media. 
The selectable genetic markers studied, their phenotypes, and the compo­
sition of the media used to select and score them, are listed in Table 
5. 
The unselectable markers studied were a-hemolysin production and 
chromosomal 3"lactamase production (the Ps53bla locus; Boston, 1965) 
which is inducible in strain ISP 163. Either CDS agar or BHI agar was 
used to score penicillinase production. The basal medium was prepared 
to contain 0.3% (w/v) soluble starch, and received filter-sterilized 
2-(2'-carboxyphenyl) benzoxyl-6-aminopenicillanic acid (CBAP; Sigma) at 
a final concentration of 7.25 yM (Imsande and Lilliholm, 1976) as 
a gratuitous inducer. Recombinants exhibiting zones of starch hydrolysis 
(i.e., bla^ or penicillinase producers) were scored by momentarily flooding 
the plate with a freshly prepared solution of penicillin (30 mg/ml of 
K penicillin G; Sigma) in 0.08 M + 0.04 M KI (Perret, 1954). Hemolyt' -
activity (phenotype Hla^) was scored on rabbit or sheep blood agar (KBA 
or SEA), prepared by adding 5% (v/v) citrated rabbit or sheep blood to 
molten (45C) TSA. 
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Table 4. Composition of complete defined synthetic agar^ 
Ingredient Amount^ Ingredient Amount*^ 
glucose : 5 gm amino acids ; 
L-glutamic acid 100 mg 
salts ; L-serine 30 mg 
K^HPO^ 7 gm L-methionine 3 mg 
2 gm L-tyrosine 50 mg 
Na^ citrate.211^0 0. 4 gm L-alanine 60 mg 
MgSO^ 0. 05 gm L-lysine 50 mg 
""4'2=°4 1 gm L-threonine 30 mg 
L-phenylalanine 40 mg 
vitamins ; 
L-histidine 20 mg 
thiamine 1 mg glycine 50 mg 
niacin 1. 2 mg 
L-tryptophan 10 mg 
biotin 0. 005 mg 
L-isoleucine 30 mg 
Ca pantothenate 0. 25 mg 
L-valine 80 mg 
purines and pyrimidines;*^ L-leucine 90 mg 
adenine 5 mg L-aspartic acid 90 mg 
guanine L-arginine 50 mg 5 mg 
cytosine 5 mg L-proline 80 mg 
uracil 5 mg L-cystine 20 mg 
thymine 20 mg Difco agar 15 gm 
deionized water 1000 ml 
^Synthetic media were prepared by combining required volumes of each 
stock; these mixtures were sterilized by passage through GSWP047 Milli-
pore filters and combined with the Difco agar which had been previously 
autoclaved (121C, 15 min) with the remaining water and cooled to 50C. 
^Final concentration per liter. 
"^Normally omitted unless required for the growth of desired strain 
or class of recombinants. 
Table 5. Selectable genetic markers, their phenotypes, and composition of selective media 
Marker Phenotype of Marker 
Modification of CDS agar to prepare 
selective medium 
nov-142 
thy- H
 
O
 
H
 
pur-110 
•
H 
129 
tmn-•3106 
mec-•4916 
nil, 07, 031, 
032= 
Nov^ resistance to novobiocin 
Thy thymine requirement 
Pur adenine and guanine requirement 
Ilv isoleucine and valine requirement 
Tmn^ resistant to tetracycline-
minocycline 
Mec^ resistance to methicillin 
Em^ resistance to erythromycin 
+10 yg novobiocin per ml 
-thymine 
-adenine and guanine 
-isoleucine and leucine; valine reduced to 
20 yg/ml; +1% sodium pyruvate^ 
+1 yg (3.0 yg)^ of tetracycline per ml 
+6.25 yg of methicillin per ml +5% NaCl 
(Lacey, 1972) 
+10 yg erythromycin per ml 
Sodium pyruvate added to facilitate growth of Ilv transformants. 
^Concentration in parenthesis used to score unselected markers among recombinants. 
°Each n designation represents a chromosomal insertion of a translocatable element carrying 
the erythromycin-resistance determinant of the pI258 plasmid in Staphylococcus aureus (Novick 
et al., 1978). Several strains carrying this translocon, integrated at different sites on the 
chromosome, were examined in this study. A detailed description of these elements is given in 
the Bacteria and Bacteriophages section of MATERIALS AND METHODS. 
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Phage typing was performed on TSA supplemented with 5 X 10 M 
CaClg. 
Preparation of Transforming Deoxyribonucleic 
Acid (DNA) 
DNA was prepared according to a modification (Pattee and Neveln, 
1975) of the procedure of Lindberg et al. (1972). A 150-ml volume of TSB 
was inoculated with the culture from which DNA was to be extracted and 
incubated overnight at 37C. The cells were then harvested (10,000 X g, 
20 min, 4C), washed once with Tris-NaCl-EDTA buffer, pH 7.4 [0.1 M Tris 
(hydroxymethyl) amino methane, 0.15 M NaCl, 0.1 M (ethylenedinitrilo) 
tetraacetic acid] and resuspended in 5 ml of the same buffer in a 50-ml 
screw-capped flask. Lysostaphin (300 yg; Schwarz-Mann, Orangeburg, N.Y.) 
was added and the mixture was incubated with shaking (100 cycles per min, 
3.8 cm strokes) for 30 min at 35C. Pronase (10 mg; Calbiochem, La Jolla, 
Ca.), which had been pre-incubated at 35C for 30 min, was added and incu­
bation with shaking was continued for 5 min, followed by incubation 
without shaking for 55 min. Then 0.5 ml of sodium dodecyl sulfate-
ethanol (5% SDS in 45% ethanol in water) was added and the flask was 
shaken vigorously on a Burrell wrist-action shaker (Burrell Corp., 
Pittsburgh, Pa.) for 30 min at room temperature. The lysis mixture was 
then extracted twice under subdued illumination with equal volumes of 
freshly distilled (under N^ gas) phenol saturated with 0.01 M Tris-HCl 
buffer, pH 8.1. Extractions were performed on a Kraft RD-250 rotator 
equipped with a RD-30-18 rotator head (Kraft Apparatus Inc., Mineola, N.Y.) 
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turning on a horizontal axis at 60 rpiti for 30 min. After each extrac­
tion, the emulsion was separated into its component phases by centri-
fugation (8,000 X g, 45 min, 4C) and the aqueous upper layer removed. 
The aqueous phase from the second extraction was washed with 20 ml of 
ethyl ether, and the residual ether removed with a stream of gas. 
The DNA was then precipitated by adding 2 volumes of cold 95% ethanol, 
spooled on a glass rod, and stored overnight under 95% ethanol. The 
DNA was then dissolved in SSC (0.15 M NaCl and 0.015 M trisodium citrate, 
pH 7.2), and stored at 4C. DNA was assayed by the diphenylamine colori-
metric reaction (Burton, 1956); the bacteriological sterility was con­
firmed by spreading about 0.2 ml on a BHI agar plate. 
Transformations 
Competent cells for transformation were prepared by a modification 
(Pattee and Neveln, 1975) of the procedure described by Lindberg et al. 
(1972). Cells from an overnight BHI agar slant culture of the recipient 
strain were suspended in 5 ml of saline (0.85% NaCl). A sufficient amount 
(ca. 1 ml) of this suspension was used to inoculate a 100-ml volume of TSB 
in a nephelometer flask to attain an optical density of 0.1 (X = 540 nm) . 
Ten-ml volumes of this suspension were used to inoculate 100-ml volumes of 
TSB in 300-ml nephelometer flasks, which were incubated with reciprocal 
shaking (100 cycles per min, 3.8 cm strokes) at 35C. At an absorbancy of 
about 0.15 the cells were harvested (10,000 X g, 20 min, 4C), washed 
once with cold Tris-maleate buffer [0.1 M Tris(hydroxymethyl)amino-
methane and 0.1 M maleic anhydride, pH 7.0], and finally resuspended in 
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the same buffer containing 0.1 M CaCl^- One milliliter of CaCl^-con-
taining buffer was used for every 100 ml of original culture harvested. 
I 
One-ml volumes of the cells (in Tris-maleate-Ca buffer) were immediately 
transferred to 15-ml Corex centrifuge tubes containing 0.1-ml portions of 
DNA or to empty tubes (cell controls). The tubes were gently mixed and 
held in an ice bath for 2.5 min, followed by incubation for 2.5 min at 
35C. The cells were then harvested (3,400 X g, 7 min, 22C); each pellet 
was resuspended in 1 ml of BHI and incubated with shaking at 35C for 30 
min. This suspension was harvested and the pellets resuspended in 1 ml 
of saline. Aliquots (0.1 ml) of this suspension, with or without further 
dilution in saline, were spread on the appropriate selective media to 
assay for transformants and revertants. In some experiments DNA controls 
were also included by preincubating the transforming DNA with deoxyribo-
nuclease prior to its addition to the cells. The absence of recombinants 
from the DNA controls confirmed the transforming activity and sterility 
of the DNA. Viable cell counts were obtained on complex media (sheep or 
rabbit blood agar). Colonies were scored after incubation at 35C for 
48 to 72 h. 
Competence for transformation in strains unable to attain competence 
naturally was effected by using phage 55 in a helper-phage capacity 
(Thompson and Pattee, 1977). 
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Transductions 
The procedure used for transductions was a modification of that 
reported by Kloos and Pattee (1965). The recipient strain was grown over­
night on a BHI agar slant at 35C. The cells (about 5 X 10^^ CPU) were then 
harvested in 1 ml of TSB and 0.5 ml of this suspension placed into each of 
two corex centrifuge tubes. One tube (control) received 1.5 ml of TSB 
while the other received 1.0 ml of TSB and 0.5 ml of the transducing 
phage lysate (with a titer of 10^^ to 10^^ PFU/ml). These mixtures were 
incubated at 35C with shaking for 10 min, harvested by centrifugation, and 
the pellets resuspended in 1 ml of BHI. Incubation was continued for 30 
min; each tube then was chilled in an ice bath and 1 ml of 0.02 M sodium 
citrate was added. The cells were harvested and the pellets were re-
suspended in 1 ml of cold sodium citrate. Samples of the dilute and con­
centrated transduction suspension, and of the concentrated control sus­
pension, were spread onto appropriate selective media. 
Hemolytic Assays 
As previously mentioned, the hemolytic activity of recombinant popu­
lations was assayed on either RBA or SEA. Since background growth of the 
nonrecombinant population on blood agar plates interfered with assessment 
of hemolytic activity, velveteen replication of the recombinants from 
selective media to blood agar was not feasible. Therefore, the re­
combinants were picked (via sterile toothpicks) from the selective media 
to blood agar plates. Following growth on blood agar, the recombinants 
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were replicated to appropriate media to score unselected markers. Tube 
assays for hemolysins were performed by making two-fold dilutions of 
culture supernatants in 0.2 M phosphate buffer (pH 7.2) containing 0.85% 
(w/v) NaCl. An equal volume of a 2% suspension of washed rabbit erythro­
cytes was added to each tube and the tubes were incubated at 37C for 1 h. 
The reciprocal of the highest dilution showing complete hemolysis was 
designated as the hemolytic units (HU) per milliliter (McClatchy and 
Rosenblum, 1965a). 
A preliminary screen of hemolysin production by all strains was done 
by the cross-inoculum method described by Elek and Levy (1954) . On SBA 
plates the action of a-hemolysin is inhibited in zones exposed to $-
hemolysin, while in the same zone ô-hemolysin is potentiated. Test strains 
were streaked through a known g-hemolysin producer on SBA and examined 
for inhibition of a-hemolysin or potentiation of 6-hemolysin activity. 
Production of a-hemolysin was confirmed by inhibition of its 
hemolytic activity on RBA by anti-a-hemolysin antibody. Paper discs 
impregnated with a solution containing 142 international units per ml of 
anti-staphylococcal a-hemolysin (Wellcome Reagents Limited, Beckenham, 
England) were placed adjacent to the test inoculum on RBA plates. The 
plates were incubated for 48 h at 35C and observed for inhibition of 
a-hemolytic activity. 
42 
Fibrinolysin, Coagulase, Deoxyribonuclease, 
Protease and Lipase Assays 
An adaptation of the plate method of Lack (1956) was used to assay 
fibrinolytic activity. Sterile porcine plasma (12% v/v) was added to 
melted TSA and held at 56C for 20 min before pouring. The plates were 
inoculated with selected transformants and the degree of clearing 
(taken as evidence of fibrinolytic activity) was recorded after incubation 
for 48 h at 35C. 
Coagulase was assayed by the tube test with reconstituted rabbit 
plasma (Bacto-Coagulase Plasma, Difco). Two drops of a broth culture of 
each recombinant were added to tubes containing 0.5 ml of plasma, mixed, 
incubated at 35C, and examined at frequent intervals for clot formation. 
Thermostable nuclease activity was examined by inoculating selected 
transformants onto DNase Test Agar (Gibco). After incubation for 48 h 
at 35C, DNase activity was scored by flooding the plates with 1 N HCl 
to precipitate the unhydrolyzed DNA. While generally accepted as being 
thermostable, the thermal stability of this enzymatic activity was not 
determined in this study. 
Protease activity was examined on Staphylococcus Medium No. 110 
(Difco) and also on TSA containing 3.0% (v/w) Bacto-Gelatin (Difco). 
Selected recombinants were inoculated onto each medium and incubated for 
48 h at 35C. Protease activity (gelatin hydrolysis) was scored by flooding 
the plates with 5 ml of saturated ammonium sulfate; clear zones around 
the inoculum indicated gelatin hydrolysis. 
Lipase activity was examined on tributyrin agar prepared by adding 
5 ml tributyrin and 0.1 ml Tween 80 to 100 ml TSA. This mixture was then 
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sonicated and added to the remaining 900 ml TSA before autoclaving. 
Selected recombinants were inoculated onto the tributyrin agar, incubated 
for 48 h at 35C, and examined for zones of lipase activity. 
Phage Typing 
Selected transformants and their parent strains were phage typed 
to determine whether a change in typing pattern coincided with the 
acquisition or loss of hemolytic activity. The recombinants were first 
purified by streaking onto appropriate selective media and were then typed 
with the basic set of staphylococcal typing phages. Bacteriophages be­
longing to lytic groups I, II, IV and the Miscellaneous group were used 
only at the routine test dilution (RTD; Parker, 1972). Bacteriophages of 
lytic group III, together with phages 011, 012, and 80a, were used at the 
RTD and 10 X RTD. 
Calculation of Genetic 
Linkages 
The cotransformation frequencies of two markers whose individual 
frequencies are A and B have been expressed as the estimated co-transfer 
frequency (est c^) , where est c^ = AB/A or AB/B. Map distances between 
markers have been expressed as 1-est c^ . 
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RESULTS 
A preliminary screen of the hemolytic activities among several strains 
of Staphylococcus aureus by the cross-inoculation technique (Figure 1) 
indicated that there is considerable diversity among strains in their 
production of hemolysins (Table 6). 
Preliminary Mapping Experiments 
When this study was initiated, the defined chromosomal linkage groups 
in Staphylococcus aureus were as follows (Pattee and Neveln, 1975; 
Pattee et al., 1977; Pattee et al., 1978; Kuhl et al., 1978); 
Linkage group I; fill - thy-101 - (lys-115,thrAllS) -fi8 - trp-103 -
thrBlOS - fi40 
Linkage group II: pyr-141 - hisGblS - nov-142 - pur-102 - mec4916 
Linkage group III: fi34 - fi5 - tmn-3106 - attpll - (fi42, fiSO) - (fil, 
fi7, fiSl) - pur-110, bla^ - ilvRlO - ilv-129 - pig 131 
It is within the framework of these three linkage groups that the 
determinant(s) controlling a-hemolysin production were sought in this 
study. 
Strain 8325nov-142,pig-131,hla-156 (ISP 2) was nonhemolytic on SBA 
(Table 6) and was presumed to possess a spontaneous mutational lesion 
(hla-156) responsible for its inability to elaborate a-hemolysin. 
Initial transformations of ISP 2 with DNA from strains 8325-3fill[Chr;;Tn551], 
tmn-3106,nov-142 (ISP 276) and 8325fil2[Chr;;Tn551],tmn-3106,nov-142 
(ISP 278) indicated that the mutant allele for a-hemolysin production 
was linked to the tmn-3106 locus in linkage group III. Selection in each 
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Figure 1. A strong ^-hemolytic strain (left vertical streak) and a 
strong a-hemolytic strain (right vertical streak) were 
inoculated at right angles to a strong 3-hemolytic strain. 
Potentiation of the ô-hemolysin and inhibition of 
a-hemolysin are apparent within the 3-hemolytic zone 
Table 6. An analysis of hemolysin production in strains of Staphylococcus aureus as determined 
on sheep blood agar by the cross-inoculum technique® 
Strain Hemolysins 
a 6 ^ 
Hemolysins 
a 3 t 
Hemolysins 
a e <: 
ISP 1 ++ - - ISP 278 ++ - 4- ISP 436 - - -
ISP 2 - - - ISP 281 - - 4-4- ISP 437 - - -
ISP 5 +++ - + ISP 283 - - - ISP 438 44-4- - 4-
ISP 8 - - - ISP 328 ++ - - ISP 439 - 4-
ISP 39 ++ - + ISP 329 ++ - - ISP 440 4-4-4- - 4-
ISP 44 + - ++ ISP 331 - - 4-4- ISP 441 - - -
ISP 93 - - - ISP 335 ++ - - ISP 442 - - -
ISP 94 - - - ISP 380 - 4-4- - ISP 443 4-4-4- - -
ISP 99 ++ - ++ ISP 383 - - - ISP 444 4-4-4- - -
ISP 103 ++ - + ISP 425 +++ - - ISP 445 4- 4-H- 4-
ISP 161 - - - ISP 426 - - - ISP 446 4-4-4- - 4-
ISP 163 - - - ISP 427 - - - ISP 448 -f4"<- - 4-
ISP 167 - ++ + ISP 428 +++ - - ISP 449 4-4-4- - 4-
ISP 171 - - - ISP 429 +++ - - ISP 460 - - -
ISP 196 - ++ - ISP 430 +++ - - ISP 461 - - -
ISP 197 ++ ++ - ISP 431 +++ - - ISP 462 - - -
ISP 227 - - - ISP 432 +++ - - ISP 463 - - -
ISP 230 + - ++ ISP 433 - - - ISP 464 - - -
ISP 265 - - - ISP 434 - - ISP 465 4-t- - -
ISP 276 ++ - + ISP 435 - - -
^Hemolysin pattern of strains determined by cross-inoculation (Elek, 1959) through &-
hemolysin-producing strain (see Figure 1). 
^Because of considerable diversity in the sizes of hemolytic zones produced by each strain 
in separate tests, the hemolytic activity is qualitatively scored as +++ = high activity, 
++ = moderate activity, + = slight activity, and - = no hemolytic activity detected. 
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case was for Tmn^ and Em^ recombinants. Of 383 Tmn^ recombinants of 
ISP 2 recovered by transformation with DNA from ISP 276, 23 (6%) had also 
acquired the donor allele for a-hemolysin production (hia"*") . In the 
same cross, 195 Em^ recombinants were examined and none produced a-
hemolysin. The fill element resides in linkage group I (Novick et al., 
1978) and is unlinked to tmn-3106 by transformation. The absence of 
Em^Hla^ recombinants thus lent further support to the conclusion that 
the Tmn^Hla^ recombinants represented true linkage. In the cross using 
DNA from ISP 278, a-hemolysin production exhibited 2% cotransformation 
with Tmn^. Representative Hla^ recombinants in both crosses were tested 
for a-hemolysin activity by the cross-inoculum technique (Figure 1). 
The a-hemolytic activities of selected recombinants were also confirmed 
by inhibition of the hemolytic zones by a-hemolysin antiserum on rabbit 
blood agar (Figure 2). 
In order to confirm the linkage of the a-hemolysin determinant to the 
tmn-3106 marker, and also to determine its relative position to the left 
or right of tmn-3106, ISP 2 was transformed with DNA from strains 8325-4J27 
[Chr;;Tn551] (ISP 197), 8325(80a)Q31[Chr;;Tn551],tmn-3106,nov-142 (ISP 328), 
and 8325 (80a) ^232 [Chr: ;Tn551'J,tmn-3106,nov-142 (ISP 329); selection was for 
Em^ in each case, 0,1 and 031 lie to the right of tmn-3106 in linkage group 
III, and have similar, if not identical, integration sites between 
att011 and pur-110. The 032 determinant lies to the left of tmn-3106 and 
exhibits about 50% cotransfer with it. An analysis of about 100 Em^ 
recombinants in each of the above crosses showed that hla^ cotransformed 
about 60% of the time with 07 and 031. However, when 106 Em^ recombinants 
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Figure 2. Inhibition of a-hemolytic activity by anti-staphylococcal 
a-hemolysin antiserum on rabbit blood agar 
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obtained with the 032 donor were examined, none were Hla^. Furthermore, 
selection of Tmn recombinants in the appropriate crosses again showed 
1-2% cotransfer of Hla* with Tmn^. These results indicated that the 
hla-156 determinant mapped to the left of tmn-3106 in linkage group III. 
Analysis of a-Hemolysin by Transformation 
Subsequent studies were aimed at determining the position of the 
hla-156 marker in ISP 2 relative to the other known markers in linkage 
group III. For this purpose, strains ISP 433 through 450 were constructed. 
Strain 8325nov-142,pig-131,hla-156,tmn-3106,pur-110,0,1 [Chr: ;Tn551] 
(ISP 436) was constructed by transforming the tmn-3106, pur-110, and 0,1 
markers into ISP 2 (Table 3) . This derivative of ISP 2 was designed to 
serve as a recipient in crosses where Em^ and Pur^ transformants would be 
selected and then scored for a-hemolysin. However, during the construc-
tion of this strain it was found that when Tmn recombinants of ISP 2 were 
scored for their acquisition of pur-110, only about 50% of the Tmn^Pur 
recombinants were Hla • These results indicated that the hla determinant 
probably resided between pur-110 and ilv-129 in linkage group III. 
These results, along with the fact that ISP 436 was not inherently competent 
(because of the loss of the 011 prophage), led to the construction of 
strain ISP 446. ISP 446 (8325thy-101,thrBl06,ilv-129,pur-110,07 
[Chr:;Tn551]) was constructed by transforming strain 8325thy-101, 
thrB106,ilv-129,pig-131 (ISP 5) with DNA from ISP 436. Em^ re­
combinants were selected and scored for acquisition of the pur-110 
allele and maintenance of a-hemolysin activity. Initial mapping 
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experiments were then performed by transforming ISP 445 with DNA from 
ISP 2. 
Strain 8325thy-101,thrB105,ilv-129,pig-131,pur-110[Chr;;Tn551] 
(ISP 445) was transformed with DNA from strain 8325nov-142,pig-131, 
+ + + 
hla-156 (ISP 2); selection was for Pur and Ilv . The Pur recombinants 
were then scored for Em, Hla, and Ilv, while the Ilv^ recombinants were 
scored for Pur, Em, and Hla. Recombinants were picked from the selective 
media to SBA or RBA to score hemolysin activity (Figure 3), and then 
replicated from the blood agar to selective media to score the other un-
-J-
selected markers. Table 7 shows the Pur and Ilv transformation 
"î* *t" 
frequencies and the analysis of phenotypes among 1393 Pur and 842 Ilv 
transformants• 
An analysis of the 9,1, pur, and hla markers among the Pur^ trans­
formants (Table 7) shows that ^ 7 and hla segregate independently. Of 
S + 
941 Em Pur transformants (classes b, d, f, and g) only 588 or 52% 
— -f- — (classes d and f) had also become Hla . Likewise, of 794 Pur Hla trans-
S formants (classes c, d, e, and f) only 588 were also Em (classes d and 
f). However, an examination of the hla marker relative to pur and ilv 
+ + 
shows that among 370 Pur Ilv transformants (classes e, f, g, and h) , 355 
or 96% were also Hla (classes e and f). Classes g and h, were hla 
was not cotransformed with pur and ilv, are presumed to represent rare 
quadruple crossovers. These results are consistent with the order of 
markers previously defined in linkage group III (Pattee et al., 1977) 
and,of greater significance, they demonstrate unequivocally that the 
hla-155 marker is between pur-110 and ilv-129. 
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Figiare 3. Analysis of a-hemolytic (Hla*) and nonhemolytic (Hla") re­
combinants on sheep blood agar. Colonies were picked (using 
sterile toothpicks) from selective media 
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Table 7. Transformation of strain 8325thy-101,thrBlOG,ilv-129,piq-131, 
pur-110,n7[Chr;:Tn551], with DNA from 8325nov-142,piq-131, 
hla-156 
Selection for 
Frequency^ of 
+ 
Pur Ilv* 
Transformation 1110 792 
Reversion <5 <5 
Relevant markers 
Donor; 
Recipient: 
Em 
S 
R 
Analysis of phenotypes; 
Of 1393 Pur^ transformants; 
17.5% (244) R 
24.5% (341)JT" 
8.3% (115) R 
23.2% (323)Js  
6.5% (91) R 
19.0% (265)J~S" 
0.9% (12 )_fs" 
0.1% (2) R 
R 
Of 842 Ilv transformants: 
40.5% (341) 
52.0% (438) 
2.3% (19) 
4.8% (40) 
0 .2% (2)  
0.1% (DJS" 
0.1% (1) R 
Pur Hla Ilv 
+ I 
T-l_ 
1_ 
L_ 
L_ 
Recom­
binant 
class; 
a 
b 
c 
d 
e 
f 
g 
h 
1 
j 
k 
1 
m 
n 
o 
a 9 9 
Expressed as colonies recovered per 10 CPU; 1.1 x 10 CPU and 
150 yg of DNA were used per ml of the transformation suspension. 
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Further support for the hla-156 marker being between pur-110 and 
ilv-129 was obtained from the analysis of Ilv^ recombinants (Table 7). 
The marker most frequently cotransformed with ilv was hla (class i). Also, 
of 61 Pur^Ilv^ transformants (classes k, 1, n, and o), 59 (classes k and 1) 
had also acquired the donor Hla phenotype. The relative order of markers 
is consistent with that obtained by Pur^ selection and demonstrates that 
the hla-156 marker resides between pur-110 and ilv-129 in linkage 
group III. 
Figure 4 shows the linkage relationships among the Çll, pur-110, 
hla-156, and ilv-129 markers in strain 8325. The distances between markers 
are expressed as 1-est c_. calculated from the distribution of unselected 
markers among the transformants shown in Table 7. The calculation of 
1-est £. for the hla-156 marker relative to pur-110 and ilv-129 shows that 
it is approximately equidistant between these two markers. The order and 
relative distances of other markers is consistent with previous results 
(Pattee et al., 1978). 
Because the 3-lactamase determinant of strain Ps53 is known to map 
between pur-110 and ilv-129 (Pattee et al., 1977), it was of interest to 
determine the linkage relationship of the bla^ locus to the hla-156 marker. 
Therefore, ISP 446 (8325thy-101,thrB106,ilv-129,pig-131,pur-110,^7 
[Chr:;Tn551]) was transformed with DNA from ISP 163 (8325nov-142,tmn-3106, 
bla ,piq-131,hla-156); selection was for Pur and Ilv . The Pur 
recombinants were then scored for Em, Pc, Hla, and Ilv, while the Ilv^ 
recombinants were scored for Em, Pc, Hla, and Pur. An analysis of 
phenotypes among 746 Pur^ transformants (Table 8) placed the bla^ locus 
Q.7 pur-IIO hla-156 ilv-129 
.32 .43 
.93 
.95 
Figure 4. Linkage relationships among the fl7[Chr;;Tn551], pur-IIP, hla-156, and ilv-129 
markers in strain 8325. Numerical values are 1—est c^. taken from the analysis of 
unselected markers shown in Table 7; arrows point from the selected markers 
to the unselected markers 
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Table 8. Transformation of strain 8325thy-101,thrBl06,ilv-129,pig-131, 
pur-110,^7[Chr::Tn551], with DNA from 8325nov-142,tmn-3106, 
bla"^,pig-131,hla-156 
Frequency of 
Transformation 
Reversion 
Selection for 
Pur Ilv 
2165 
<5 
2591 
<5 
Donor: 
Recipient: 
Analysis of phenotypes: 
Of 745 Pur^ transformants: 
6.8% (51) 
Relevant markers 
Em Pur Pc Hla Ilv 
R 
R 
4.0% (30)Js  
3.2% (24)  R_ 
9.3% (69)_fs~ 
8.9% , (65)  R 
30.4% (227)_f?  
9.4% (70)  R 
27.4% (204)  
0 .5% • (4)  
0.1% (1)_[^ 
Of 708 Ilv^ transformants: 
33.5% (237)  
51.3% (363)  
4 .1% (29)  
3 .1% (22)  
7 .8% (55)  
0.1% (1) 
0.1% 
R 
S 
(DJS" 
R 
R 
R 
R 
R 
S 
R 
S 
1 
TL 
1 
1 
TL 
TL 
Recom­
binant 
class; 
a 
b 
c 
d 
e 
f 
9 
h 
i 
j 
k 
1. 
m 
n 
o 
P 
q 
a 9 8 
Expressed as colonies recovered per 10 CFU; 9.2 x 10 CPU and an 
excess of DNA were used per ml of the transformation suspension. 
56 
between pur-110 and hla-156 because 567 Pur Hla recombinants (classes 
e, f, g, and h) all were Pc^. When the Pur^ transformants were also 
analyzed for Em and Ilv, an order of markers consistent with the previous 
cross was obtained. 
The phenotypes of 708 Ilv^ transformants (Table 8) confirmed that 
bla^ lies to the right of hla-156 and between pur-110 and ilv-129. The 
Pc phenotype segregates independently of Ilv and Hla; out of 470 
^ — 
Ilv Hla transformants (classes 1, m, n, o, and q) 364 or 77% (classes 
1 and q) remained sensitive to penicillin. Likewise, only one trans­
formant (class p) out of 106 Pc^Ilv^ transformants (classes m, n, o, and 
p) did not exhibit the Hla phenotype. 
Figure 5 shows the linkage relationship among 9.1, pur-110, bla , 
hla-156, and ilv-129 in strain 8325. The distances between markers are 
expressed as 1-est £. calculated from the distribution of unselected 
markers among the transformants shown in Table 8. The order of markers 
is the same as that established in the previous cross (Figure 4); 
however, there is an overall decrease in the distances between all 
markers. This variability in the relative distances between markers 
may result from differences in DNA quality in each cross (Pattee 
et al., 1977) . The most significant decrease in map distance was 
between the pur and hla markers where the 1-est c. value decreased 
from 0.43 (Figure 4) to 0,24 (Figure 5). In addition to differences 
in DNA quality, the linkage between pur and hla might also be affected 
by the fact that the donor DNA contains the bla determinant, a probable 
integrated determinant, while the recipient does not contain this 
Q.7 pur-IIO bio* h 10-156 ilv-129 
-J-
Figure 5. Linkage relationships among the 0.1 [Chr: :Tn551] , pur-110, bla , hla-156, and 
ilv-129 markers in strain 8325. Numerical values are 1-est c. taken from the 
analysis of unselected markers shown in Table 8; arrows point from the selected 
markers to the unselected markers 
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segment of genetic information. Such a relationship has the potential 
to reduce (perhaps significantly) the opportunity for recombination 
between pur and hia in the region of the bla^ insertion, preserving 
genetic linkage between pur and hla, and thus increasing the probability 
of pur•and hla being inherited together. This preservation of linkage 
would have a compensating effect on the predicted reduction in linkage 
because of increased physical distance between pur and hla. Pattee 
et al. (1977) have reported similar findings relative to integrated 
plasmids or prophage between the tmn-3106 and pur-110 markers in this 
linkage group. 
On the basis of these two crosses, this linkage group can now be 
defined as; 034 - 05 - tmn-3106 - att011 - (Ql, Çf!, fl31) - pur-110 -
bla"*" - hla-156 - ilv-129 - piq-131. 
All crosses thus far have been intrastrain crosses involving strain 
8325 of Staphylococcus aureus. To ascertain whether the same genetic 
determinant(s) affecting a-hemolysin production might be common to other 
strains of Staphylococcus aureus, several a-toxin-negative mutants of 
strain 233 were obtained. Unlike the Hla mutants of strain 8325, these 
mutants of strain 233 were induced by treatment with nitrous acid or 
UV-irradiation (McClatchy and Rosenblum, 1966a,b). On the basis of two-
point reciprocal transductions, these mutants had been placed into two 
genetic groups (McClatchy and Rosenblum, 1966b). Mutants of group I were 
believed to contain lesions in a structural gene affecting only a-
hemolysin production, while the group II mutants were thought to be 
regulatory mutants defective in a-hemolysin as well as fibrinolysin 
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production. Representatives of each group were analyzed by transfor­
mation with strain 8325thy-101,thrBl06,ilv-129,pig-131,pur-110,tmn-3106 
(ISP 448), 
Table 9 shows the results of the transformation of ISP 448 with 
DNA from group II strain 233hla-151 (ISP 461); selection was for Pur^ 
and Ilv"*". The Pur^ transformants were scored for Hla, Ilv, and Pig, 
while the Ilv transformants were scored for Hla, Pur and Pig. The Pur 
9 
transformation frequency of 367 transformants per 10 CPU is significantly 
lower than that obtained in intrastrain crosses (Tables .7 and 8). This could 
be attributed to incompatibility of the two strains; however, the Ilv^ 
frequency did not exhibit a similar reduction. The analysis of pheno-
types among 186 Pur^ transformants shows that the hla-151 marker is 
linked to pur-110 (classes b and c) ; however, the cotransformation 
frequency of 13.9% is also considerably lower than that obtained in 
intrastrain crosses (Tables 7 and 8) . It should also be noted that only one 
— -J- -f* 
Pur Hla Ilv transformant (class c) was recovered among 186 Pur trans­
formants. This is a significant reduction from the 30% to 40% co-
transformation frequency of pur-110 and ilv-129 found in the intra­
strain crosses. These results indicate that the donor strain may con­
tain a nonhomologous segment of DNA (i.e., prophage or plasmid) between 
pur and hla which is not only affecting the recovery of Pur^ transfor­
mants but also the linkage of pur to hla or ilv. 
An analysis of 221 Ilv^ transformants in the same cross shows that 
the Hla marker cotransforms with IIv^ (classes f and h) about 50% of the 
time. This frequency is only slightly lower than the intrastrain 
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Table 9. Transformation of strain 8325thy-101,thrBlOG,ilv-129, 
pig-131,pur-110,tmn-3106 with DNA from strain 233 hla-151 
Selection for 
Frequency of: 
Transformation 
Reversion 
Pur 
367 
<5 
Ilv 
1729 
<5 
Relevant markers 
Pur Hla Ilv Pig 
Donor : 
Recipient: 
Analysis of phenotypes; 
Of 186 Pur* transformants: 
86, .0% (160) _J 
13. 4% (25) _[ 
0. ,5% (1) _J 
0. ,0% (0) _J 
Recom­
binant 
class; 
a 
b 
c 
d 
Of 221 Ilv transformants: 
29.9% (66) 
29.0% (64) 
19.9% (44) 
21.3% (47) 
0.0% (0) __pr 
0.0% (0) __[T 
e 
f 
9 
h 
3, 9 8 
Expressed as colonies recovered per 10 CFU; 8.5 x 10 CFU and 
an excess of DNA were used per ml of the transformation suspension. 
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frequency (Figure 4); however, none of the Ilv^ transformants coinherited 
the donor Pur^ phenotype (classes i and j). Since the donor strain was 
phenotypically Pig^ and since a determinant affecting pigmentation is 
known to reside to the right of ilv-129 in linkage group III (Pattee, 
1976), the transformants were also scored for pigmentation. None of 
the Pur transformants acquired the Pig allele (class d) . However, because 
"J" 
91 Ilv transformants were also Pig (classes g and h) and because the 
hla-151 marker segregated independently of Ilv Pig (class g), it 
appears that the pig determinant is allelic in these strains. 
When ISP 448 was transformed with DNA from one of the group I 
mutants of strain 233 (ISP 463), the results (Table 10) were essentially 
identical. The frequency of transformation of Pur^ was low in comparison 
•)* 
to the Ilv frequency and the analysis of phenotypes among the Pur and 
Ilv recombinants exhibited the same distribution of unselected markers. 
Figure 6 shows the linkage relationships among pur-110, hla-151, 
hla-153, ilv-129, and pig-131 markers in strain ISP 448 obtained with 
both groups of nonhemolytic mutants of strain 233. The map distances 
between markers are expressed as 1-est £. calculated from the distribution 
of unselected markers among transformants in each cross (Tables 9 and 
10). The map distances are virtually identical for both crosses. The 
major differences observed between intrastrain and interstrain crosses 
are the reduction in Pur* transformation frequency found in both inter­
strain crosses (Tables 9 and 10) and the reduction in the linkage of 
pur and hla markers (Figure 6). 
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Table 10. Transformation of strain 8325thy-101,thrBl06,ilv-129,pig-131, 
pur-llOftmn-3106, with DNA from strain 233 hla-153 
Frequency of: 
Transformation 
Reversion 
Selection for 
Pur 
573 
<5 
Ilv 
1212 
<5 
Relevant markers 
Pur 
Donor: + 
Recipient: 
Analysis of phenotypes: 
Of 230 Pur^ transformants; 
87.0% (201) _j + 
10.4% (24) _] + 
2.2% (5) _JT 
0.0% (0) _fT 
Of 222 Ilv^ transformants: 
24.8% (55) 
33.8% (75) 2^ 
22.5% (50) 
18.9% (42) -
0.0% 
0.0% 
(0) _JT 
(0) _pr 
Hla Ilv Pig 
— + + 
Recom­
binant 
class; 
a 
b 
e 
f 
g 
h 
a 9 8 
Expressed as colonies recovered per 10 CFU; 8.5 x 10 CPU and an 
excess of DNA were used per ml of the transformation suspension. 
pur-IIO 
(hla-153) 
hlo-ISI ilv-129 pig-131 
(>.99) 
(>.99) 
cr> Ul 
Figure 6. Linkage relationships among the pur-110, hla-151, hla-153, ilv-129, and pig-131 markers 
in strain 8325. Numerical values are 1-est c. taken from the analysis of unselected 
markers shown in Tables 9 and 10; arrows point from the selected markers to the un­
selected markers f The map distances were obtained with DNA from ISP 461, which 
carries the hla-151 marker. Map distances in parentheses were obtained with DNA from 
ISP 463, which carries the hla-153 marker 
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In both of the interstrain crosses (Tables 9 and 10) it was also 
observed that a consistent percentage (ca. 5%) of the Pur Hla re­
combinants exhibited zones of hemolysis which differed from the zones 
normally produced by strain ISP 448 (Figures 7a and 7b) . The Hla^ 
recombinants typically produce an inner zone of complete hemolysis 
which is surrounded by a larger outer zone of incomplete (hazy) 
hemolysis (Figures 7a and 7b) . The atypical Hla* recombinants exhibited 
an enhanced hemolysis which resulted in a larger, slightly more diffuse 
zone of hemolysis, which in many cases contained an outer precipitin 
ring (Figures 7a and 7b)• That all of these transformants were pro­
ducing a-hemolysin was confirmed by the fact that each of the different 
zones was inhibited by a-hemolysin antiserum. These varied hemolytic 
reactions clearly need further study; however, it does appear that 
other extracellular products may be associated with a-hemolysin produc­
tion. McClatchy and Rosenblum (1966b) suggested the possibility of 
coordinated control of fibrinolysin and a-hemolysin production in the 
group II mutants of strain 233. Both groups of mutants of strain 233 
probably contain mutational lesions in the same gene based on their 
apparent identity in transformation experiments (Figure 6). It is 
possible that the hla determinant examined in all of these strains repre­
sents a common regulatory mechanism involved in the synthesis or re­
lease, or both, of several exoenzymes. An examination of the possible 
pleiotropic effect of this locus on other extracellular enzymes is 
reported below. 
Figure 7a. Rabbit blood agar showing variability in a-hemolytic zones 
obtained among Pur"^ transformants in crosses of Hla donors 
and Hla* recipients. Transformants producing larger zones 
with precipitin halo represented about 5 to 10% of the 
Pur^Hla recombinants 
Figure 7b. Rabbit blood agar 
(left center) and 
.center) 
showing typical Pur^Hla* recombinant 
atypical Pur Hla"^ recombinant (right 
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Because the strains examined thus far exhibited apparent identity in 
the mutational lesion affecting «-hemolysin production, it was of interest 
to examine other hemolysin-deficient mutants of Staphylococcus aureus for 
linkage of the hla determinant to pur-IlO in linkage group III. Strains 
ISP 93, ISP 94, ISP 171, ISP 227, ISP 283, ISP 380, and ISP 383 were 
used to transform ISP 448; Pur^ transformants were selected and then 
scored for loss of a-hemolysin on RBA. Table 11 shows the results ob­
tained in these crosses. In each case the hla determinant cotrans-
formed with pur-110 at a frequency consistent with that obtained in 
previous intrastrain crosses (Figures 4 and 5) . The Pur^ transformation 
frequency in each of these crosses was also consistent with that obtained 
in previous intrastrain crosses; therefore it is reasonable to assume 
that the hla determinant in each of these mutants is allelic with the 
hla-156 determinant in ISP 2 and ISP 163. 
In all the crosses shown in Table 11, a consistent percentage (7 
to 10%) of the Pur^ transformants exhibited the same heterogeneity of 
hemolytic activity seen when strain ISP 448 was transformed with DNA 
from the nonhemolytic mutants of strain 233 (Figures 7a and 7b) • How­
ever, this heterogeneity of hemolytic activity had not been observed 
in the cross of ISP 445 with DNA from ISP 2 (Table 7) ; therefore this 
phenomenon was reinvestigated. Strains ISP 446 and ISP 448 differ only 
R S 
in that ISP 448 is a Tmn Em recombinant of ISP 446. The possibility 
existed that the presence of the tmn-3106 determinant or absence of the 
9.1 determinant in ISP 448 could affect the production or release of a-
hemolysin and account for the heterogeneity in hemolytic zones. However, 
Table 11. Transformation of strain 8325thy-101,thrB106,ilv-129,pig-131,pur-110, tmn-3106 with 
DNA from a-hemolysin-deficient (Hla") strains of Staphylococcus aureus 
Pur 
Donor strain Transformation 
a 
Frequency 
Number of 
Pur"*" 
Transformants 
Tested 
Number of 
Hla" 
Trans formants 
1-est c. 
value 
ISP 93 Ps6tmn-3106,hla-162 3700 402 299 .26 
ISP 94 Ps6tmn-3511,hla-162 2175 273 193 .29 
ISP 171 8325-401[Chr::Tn551],tmn-3106, 
hla-163 
4580 716 475 .34 
ISP 227 Ps6hla-162 2471 359 219 .39 
ISP 283 8325-4^5[Chr;:Tn551],tmn-3106, 
nov-142,hia-163 
2825 466 295 .37 
ISP 380 8325^46[Chr::Tn551],tmn-3106, 
hla-164 
2625 446 279 .37 
ISP 383 8325^46[Chr::Tn551],tmn-3106, 
hla-165 
1450 278 191 .31 
per 
3 9 
Expressed as colonies recovered per 10 CPU; 2.4 
ml of the transformation suspension. 
g 
X 10 CFU and an excess of DNA were used 
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all of the Pur^Hla^ recombinants of ISP 448 obtained by using DNA from ISP 2 
produced virtually identical hemolytic zones. These results indicated 
«f» 
that the heterogeneity in hemolytic zones produced by the Pur Hla 
recombinants obtained in all the other crosses must be related to a 
genetic element(s) present among the donor strain. It should also be 
noted that the linkage relationships among the pur-110, hla-156, and 
ilv-129 markers obtained in the cross of ISP 2 DNA with ISP 448 was 
consistent with the linkage relationships obtained when ISP 446 was used 
as the recipient strain. 
Phage Typing of Recombinants 
In view of the report by Blair and Carr (1961) that a converting 
phage may be responsible for a-hemolysin production in staphylococci, 
selected recombinants were purified by single colony isolation and 
phage typed. 
Forty-eight Pur^ transformants from the cross of ISP 446 (8325thy-101, 
thrB106,ilv-129,pig-131,pur-110,fl7[Chr; :Tn551]) with DNA from ISP 2 (8325 
nov-142,pig-131,hla-156) (Table 7) were typed with Staphylococcus aureus 
reference typing phages. The donor and recipient exhibited strong lytic 
reactions (+++, ++++) with phages 47 and 75 and minor reactions (+ to ++) 
with phages 53, 77, 84, and 85. Among 19 Pur Hla transformants, all 
exhibited typing reactions similar to the donor and recipient. However, 
one of these transformants had acquired a strong reaction (+++) with 
phage 83A and was also more susceptible to phages 53 and 85. Among the 
27 Pur^Hla transformants, essentially identical results were obtained. 
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All transformants were susceptible to the same phages as the donor and 
recipient, with the exception of one transformant which had acquired sensi­
tivity to phage 83A and increased sensitivity to 53 and 85. 
It is known that the presence of the 011 prophage in strain 8325 con­
fers immunity to typing phages 83A and 53 (Pattee et al., 1977). Because 
the donor and recipient both carry the 011 prophage, it appears that some 
of the recombinants spontaneously lost this prophage. Random, rare loss of 
the 011 prophage by competent cells during the transformation process has 
been reported (Limpa-Amara, 1978) . The typing patterns of the Pur^Hla* 
and Pur Hla transformants do not indicate an association of hemolysin 
activity with phage conversion on the basis of a change in lytic reaction 
with the typing phages. Also, the presence or absence of the 011 prophage 
apparently does not affect a-hemolysin production. 
Selected transformants obtained from the interstrain cross of ISP 448 
with DNA from ISP 463 (Table 10) were also typed with phages of lytic 
group III, together with phages 011, 012, and 80a. On the basis of the 
typing patterns exhibited by the various recombinant classes (Table 12) 
there is no apparent correlation between the typing patterns and produc­
tion of a-hemolysin. It should be noted, however, that the donor strain 
(ISP 463) is sensitive to phages 83A and 53, yet resistant to phage 011. 
As previously mentioned, the presence of the 011 prophage in strain 8325 
is known to confer immunity to the typing phages 83A and 53 (Pattee 
et al., 1977). It is possible that resistance to 011 in strain ISP 463 
is conferred by a prophage (related to 011) that does not confer immunity 
to phages 83A and 53. Because the att011 integration site has been 
Table 12. Phage typing patterns of strain ISP 448 (8325thy-101,thrBlOS,ilv-129,pig-131, 
pur-110, tmn-3106) , ISP 463 (233hla-153), and Pur^Hla"'"Ilv~, Pur"^Hla~Ilv~, and Pur 
Hla~Ilv''' transformants of ISP 448 with ISP 463 DNA 
Strain or 
trans formant 
No. of 
transfor­
mants 
typed 
No. 
exhibi­
tion — 
reaction 6 
Reaction to the Typing Phage' 
47 53 54 75 77 83A 84 85 jSll J312 80a 
ISP 448 
ISP 463 
ISP 448 
Pur'^ 'Hl a"*" 11 v~ 
ISP 448 
Pur+Hla-llv~ 
ISP 448_ 
Pur^Hla Ilv"*" 
16 
20 
11 
5 
10 
10 
4 
1 
- ++++ + + + 
++ +++ ++++ ++++ 
- ++++ + + + 
++ 
++++ ++++ 
++++ + 
++++ ++++ 
++++ + 
++++ ++++ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
++++ 
++++ 
++++ 
+44-+ 
++++ ++++ 
+ — 
++++ ++++ 
+ ++++ 
++++ 
++++ ++++ 
++++ 
++++ 
++++ 
++++ 
— ++++ 
++++ 
^Typing reactions are at the RTD ; ++++ = confluent lysis, +++ = 200 plaques or semi-confluent 
lysis, ++ = 50 to 200 plaques, + = 20 to 50 plaques, +.~ fewer than 20 plaques, - = no reaction. 
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mapped in Staphylococcus aureus strain 8325 between tmn-3106 and pur-110 
in linkage group III (Pattee, 1976), it is probable that this site is un­
occupied in strain ISP 463. This possibility is reinforced by the re­
covery of Pur^ recombinants of ISP 448 which are sensitive to phages 011 
and 83A (Table 12). The independent segregation of att011 among the 
Pur Hla recombinants is consistent with the att011 site being to the 
left of pur-110. Therefore, resistance to 011 in the donor strain may be 
the result of prophage immunity conferred by a phage related to 011, but 
integrated at a genomic site other than the att011 site (Limpa-Amara, 
1978)- Even though there is no correlation between a-hemolysin activity 
and these changes in phage typing patterns (Table 12), this does not 
preclude the possibility that prophages are involved in the production of 
a-hemolysin by Staphylococcus aureus. These strains of Staphylococcus 
aureus may carry prophages which are not detectable on the basis of 
resistance or sensitivity to the phages used to type these strains. 
Association of other Extracellular Products with 
a-Hemolysin Activity 
Much of the earlier literature has shown a pleiotropic association of 
a-hemolysin production with various other extracellular products of 
+ — 
staphylococci. In view of this, several Hla and Hla transformants ob­
tained in the previous crosses were analyzed for their production of 
lipase, gelatinase, fibrinolysin, coagulase, and thermostable nuclease. 
An analysis of several hundred transformants obtained in both intra-
strain and interstrain crosses showed that there is a general reduction in 
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gelatinase and thermostable nuclease production among Hla recombinants. 
However, the reduced activities of these enzymes is probably associated, 
in some aspect, only with the absence of the hemolytic protein and does not 
represent a coordinated genetic control of these activities. However, a 
nearly perfect correlation of fibrinolysin activity and a-hemolysin pro­
duction was noted. When strains in Table 3 were examined for fibrinolysin, 
it appeared that fibrinolytic activity was completely absent among non­
hemolytic strains and present in strains producing a-hemolysin. Trans­
formants obtained in crosses of these hemolytic and nonhemolytic strains 
showed that fibrinolysin (Fib) was, with few exceptions, cotransformed with 
Hla. Table 13 shows an analysis of fibrinolytic activity among Hla^ and 
Hla recombinants of ISP 448 obtained in both interstrain and intrastrain 
crosses. Of 58 Pur^ transformants of ISP 448 obtained with DNA from ISP 94 
*4" " (a derivative of Ps6), 23 Pur Hla Ilv transformants were all Fib , while 
45 Pur Hla Ilv transformants were Fib . In two intrastrain crosses of 
ISP 448 with DNA from ISP 2 and ISP 283, the same general association of 
fibrinolytic activity with production of a-hemolysin was observed (Table 
13). However, in these crosses, one Fib transformant among 58 
"4* " 
Pur Hla Ilv transformants was obtained with ISP 283 DNA. Two Fib 
*t" " 
transformants among 50 Pur Hla Ilv were also obtained in the cross of 
ISP 448 with DNA from ISP 2. 
McClatchy and Rosenblum (1966b) also reported an association of 
fibrinolysin production with a-hemolytic activity. They divided their 
nonhemolytic mutants of strain 233 into two groups; those that were 
deficient only in a-hemolysin production (group I) and those that were 
Table 13. Fibrinolysin activity of a-hemolysin negative and a-hemolysin positive transformants 
of strain 8325thy-101,thrBl06,ilv-129,pig-131,pur-110,tmn-3106 (ISP 448) 
Donor Donor Transformant Number Fibrinolysin 
strain^ Genotype Phenotype Tested Positive Negative 
ISP 94 Ps6tmn-3511,hla-162 
"t" 
Pur Hla Ilv 23 23 0 
Pur^Hla Ilv 45 0 45 
ISP 283 8325-405[Chr;;Tn551] 
tmn-3106,nov-142,hla-163 
"t* ~ 
Pur Hla Ilv 58 57 1 
Pur^Hla Ilv 20 0 20 
ISP 2 8325nov-142,piq-131, 
hla-156 
+ 4* "" 
Pur Hla Ilv 60 58 2 
Pur Hla^Ilv^ 48 48 0 
+ ~ + 
Pur Hla Ilv 50 0 50 
^Each donor strain lacked fibrinolysin as well as a-hemolysin activity. 
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deficient in a-hemolysin as well as fibrinolysin production (group II). 
They found that when Fib strains of group II were transduced with phage 
propagated on group I strains, the resulting Hla* recombinants were also 
Fib*. However, when ISP 448 was transformed with DNA from representatives 
of both of these groups (Tables 9 and 10), the Hla recombinants obtained 
in each case were also Fib . An explanation for these results is not im­
mediately evident, although when the wild type strain 233 and the nonhemo­
lytic mutants of this strain were tested for fibrinolytic activity, none 
produced fibrinolysin. It is possible that these strains have lost an 
element, such as a prophage or integrated plasmid (translocon), which is 
responsible for the synthesis of fibrinolysin. If the chromosomal site for 
this element is very close to the structural gene for a-hemolysin and a 
regulatory gene affecting production of both fibrinolysin and a-hemolysin, 
•f + 
then the transformants obtained in crosses with a Hla Fib recipient 
(ISP 448) could all exhibit a loss of fibrinolytic activity. Support for 
this hypothesis is evident from the reduced Pur* transformation frequency 
and consequent reduction in linkage of pur-110 with the hla-151 and hla-153 
determinants in interstrain crosses (Tables 9 and 10). Winkler et al. 
(1965) have reported lysogenic conversion of certain strains of Staphylo­
coccus aureus to production of fibrinolysin by serological group F 
phages; these phages are lost spontaneously from the lysogenized strains, 
resulting in the loss of fibrinolytic activity in every instance they 
examined. 
It seems likely that the genetic determinants affecting a-hemolysin 
synthesis in Staphylococcus aureus involve structural and regulatory genes 
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on the chromosome as well as the possible involvement of prophages or 
plasmids. The regulation of a-hemolysin production, and the coordinate 
control of fibrinolysin production, appears to be a trait common to 
various strains of Staphylococcus aureus. That prophages or plasmids 
may affect this regulatory element, or are responsible for the regulation 
itself, appears very likely. 
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DISCUSSION 
An initial screen of hemolytic activity among several strains of 
Staphylococcus aureus (Table 6) showed that there is considerable 
variability among strains, and also among derivatives of a particular 
strain, in their production of hemolysins. Many derivatives of strain 8325, 
obtained through various combinations of transduction or transformation 
of genetic markers, chemical or UV-induced mutagenesis, and UV-induced 
curing of prophages, show a loss of the capacity to produce a-hemolysin. 
However, the loss of a-hemolysin production cannot be attributed to any 
particular procedure or mutagenesis regimen. Strain ISP 2 (8325nov-142, 
piq-131,hla-156) was therefore selected as a prototype nonhemolytic 
derivative of strain 8325 and used to investigate the possible genetic 
linkage of the hla determinant with known markers in the three defined 
linkage groups of Staphylococcus aureus. Preliminary transformations 
demonstrated that the capacity to produce a-hemolysin (the Hla^ pheno-
type) could be cotransformed into ISP 2 with the tmn-3106 determinant in 
linkage group III. That the hla determinant was specific to linkage group 
III was further substantiated by the fact that a-hemolysin production was 
not cotransformable with markers in linkage groups I and II. Four- and 
five-factorial crosses (Tables 7 and 8) placed the hla marker between 
pur-110 and ilv-129 in linkage group III and established the linkage re­
lationship as being tmn-3106 - attjgll - (^7/^31) - pur-110 - bla^ -
hla-156 - ilv-129 - pig-131. The bla^ determinant in strain ISP 163 is 
the chromosomal ^-lactamase determinant of strain Ps53 and is probably 
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a bona fide translocatable element; thus far, however, the translocation 
of this element to other sites, chromosomal or plasmid, has not been 
demonstrated (Pattee et al., 1977). This determinant and the tmn-3106 
marker were transduced independently into ISP 2,resulting in strains ISP 
161 and ISP 163; neither marker affected the hla-156 determinant of ISP 2. 
However, in the heterologous cross (Table 8) where the bla* locus was 
absent in the recipient (ISP 446) and present in the donor (ISP 163), it 
appears that the bla.^ locus affected the co trans formation frequency of 
pur-110 and hla-156. A comparison of the Pur-Hla cotransfer frequencies in 
homologous (Figure 4) and heterologous (Figure 5) crosses shows an increase 
in cotransfer of pur-110 and hla-156 when the bla^ determinant is present 
in the donor strain. As previously mentioned, the presence of the bla^ 
determinant in the donor may have the potential to reduce the opportunity 
for recombination between pur and hla, thus preserving genetic linkage and 
increasing the probability of pur and hla being inherited together 
(Pattee et al., 1977). A single unambiguous order of markers was obtained 
from the results of both the homologous (Figure 4) and heterologous 
crosses (Figure 5). This sequence, and the linkage values among the 
markers, were consistent with previous studies of markers in this linkage 
group (Pattee et al., 1977). 
Confirmation of the fact that the locus occupied by the hla determinant 
in strain 8325 is common to other strains of Staphylococcus aureus was 
obtained in the interstrain crosses of strain 233 with 8325 (Tables 9 and 
10). The nonhemolytic mutants of strain 233 (ISP 461, ISP 463) used in 
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these crosses had been obtained by treatment of strain 233 with UV-ir-
radiation and nitrous acid (McClatchy and Rosenblum, 1966a). From the 
results of their transduction analysis of several of these a-hemolysin 
negative mutants of strain 233, McClatchy and Rosenblum (1966b) concluded 
that the mutants constituted two groups and that at least two genetic 
loci were involved in a-hemolysin production. Their genetic techniques 
were too insensitive to establish linkage of these loci; however, they 
stated that it was conceivable that each genetic group represented lesions 
in two or more adjacent or closely linked genes or cistrons. When a 
representative of each group was used as a donor by transformation with 
an a-hemolytic recipient, the results (Tables 9 and 10) demonstrate that 
both hla loci are closely linked (Figure 6). These results also show that 
the hla determinants in strain 233 are cotransformable with pur-110 and 
ilv-129 of linkage group III in Staphylococcus aureus strain 8325, sug­
gesting that the determinant or determinants affecting a-hemolysin pro­
duction are the same among various strains of Staphylococcus aureus. How­
ever, the incidence of cotransformation of the pur-110 and hla alleles 
in these interstrain crosses (Figure 6) was considerably less than that 
observed in intrastrain crosses (Figures 4 and 5). There is also a 
concomitant reduction in the Pur^ transformation frequency in both inter­
strain crosses (Tables 9 and 10). The reduction in cotransfer of pur 
and hla could be due to an increase in the actual distance separating the 
pur and hla alleles in the donor DNA, possibly related to the presence of 
any of several different integrated genetic elements in this region. This 
situation would reduce the probability of isolating both the pur and hla 
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markers on a single DNA molecule. The associated reduction in the Pur^ 
transformation frequency in both crosses tends to indicate the presence 
of prophage DNA in this region. A prophage located between pur and hla 
would not only increase the distance separating these alleles, causing 
a reduction in cotransformation, but it could also decrease the frequency 
•J" 
of recovery of Pur transformants because of transfer induction of the pro-
+ 
phage and subsequent lysis of the potential transformant. The Ilv trans­
formation frequencies were not affected in either of these interstrain 
crosses (Tables 9 and 10), and the cotransfer of hla with ilv-129 was not 
significantly lower than in intrastrain crosses. These results further 
•f" 
substantiate the view that the reduced Pur transformation frequency and 
reduction in cotrarisfer of pur and hla can be attributed to genomic 
elements near the pur-110 marker. As previously mentioned, the bla* 
determinant of strain Ps53 is known to reside between pur-110 and hla-156 
in linkage group III, and is believed to be a translocatable element 
(Pattee et al., 1977). In view of this, it is easy to imagine that there 
are similar sites between the pur and hla loci in strain 233 which could serve 
as integration sites for plasmids or prophages. A notable feature of 
linkage group III (Pattee et al., 1977) is the high frequency with which 
insertion elements map within it. 
Several other derivatives of strain 8325 (ISP 171, ISP 283, ISP 380, 
ISP 383) and strain Ps6 (ISP 227) and its derivatives (ISP 93, ISP 94) were 
also found to be deficient in a-hemolysin production. When DNA*s from 
these strains were used to transform strain ISP 448 (8325thy-101,thrBl06, 
ilv-129,pig-131,pur-110, tmn-3106) the hla locus in each donor cotransferred 
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with pur-110 (Table 13) at a frequency consistent with those obtained in 
earlier intrastrain crosses (Figures 4 and 5). 
Upon analysis of all the aforementioned crosses it is evident that the 
determinant or determinants which affect a-hemolysin production, even in 
different strains of Staphylococcus aureus, are located in the same chromo­
somal region. However, a general explanation for the loss of a-hemolysin 
production in these various strains is much less evident. Various groups 
of strains such as ISP 2, ISP 161, ISP 163, or ISP 8, ISP 167, ISP 171, 
ISP 283 (Table 3) can be related to each other since the Hla phenotype 
can be traced back to ISP 2 or ISP 8 in each group. However, an explana­
tion for the loss of hemolysin in ISP 2 or ISP 8, or other hemolytic 
negative derivatives of strain 8325 (ISP 380, ISP 383) cannot be directly 
associated with a common mutagenic treatment or genetic manipulation. 
ISP 8 and its derivatives (ISP 167, ISP 171, ISP 283; Table 3) were ob­
tained by UV-induced curing of three resident prophages in Staphylococcus 
aureus strain 8325 (Novick, 1967), indicating a possible association of 
prophage with the production of a-hemolysin. Therefore, it could be 
assumed that other strains such as ISP 2, ISP 380, or ISP 383 may have 
spontaneously lost a prophage responsible for production of a-hemolysin. 
However, under these circumstances, the precise cause for loss of hemolytic 
activity cannot be identified. McClatchy and Rosenblum (1966b) stated that 
even though they obtained their nonhemolytic mutants of strain 233 by 
nitrous acid and UV-irradiation, this did not eliminate the possibility 
that the mutants may have lost a prophage and be lysogenic for other 
closely related phages. Changes in phage type were observed among 
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recombinants obtained in this study (Table 12); however, these changes were 
not associated with the specific gain or loss of a-hemolysin. In view of 
the report by Blair and Carr (1961) that the ability to produce a-hemolysin 
may be due to phage conversion, there remains the possibility that a pro­
phage integrated in this region of the chromosome may affect a-hemolysin 
production. The results of Winkler et al. (1965) suggest that even though 
there may be structural and/or regulatory loci present on the chromosome 
for production of various extracellular products, these functions may be 
secondarily affected by the presence of prophage. Many of these earlier 
studies were performed before the present day knowledge of integrated 
replicons. It is feasible that the production of a-hemolysin and also 
fibrinolysin may be controlled by an integrated defective prophage, which 
when excised, is incapable of self-replication. 
McClatchy and Rosenblum (1966b) reported that the Hla mutants of 
strain 233 in group II were also Fib . Hla and Fib revertants were 
observed. A definite correlation of fibrinolysin and a-hemolysin pro­
duction also was found in strains 8325 and Ps6. Hla strains were also 
— + + — 
Fib , and when crossed with Hla Fib recipients, the Hla recombinants 
were, with very few exceptions, also Fib (Table 13). These results 
substantiate those obtained by McClatchy and Rosenblum (1966b) and also 
the pleiotropic association of a-hemolysin and fibrinolysin reported by 
Wheeler (1975). Forsgren et al. (1971) reported that protein A-
deficient mutants of Staphylococcus aureus Cowan I, obtained with NG and 
EMS mutagenesis were almost always impaired in their a-hemolysin activity. 
"4" 
Although protein A was not assayed among Hla and Hla recombinants in this 
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study, it is possible that the locus affecting a-hemolysin and fibrinolysin 
also affects protein A. Evidence for this possible association stems 
from the observation of fine precipitin lines surrounding all Hla^Fib^ 
recombinants on fibrinolysin agar. These precipitin lines may have 
resulted from precipitin of protein A with IgG in the porcine plasma; how­
ever, this situation clearly needs further study. 
This investigation contains the first reported linkage of determinants 
affecting a-hemolysin production to selectable markers in a defined linkage 
group of Staphylococcus aureus. The interrelationship of a-hemolysin and 
fibrinolysin reported by McClatchy and Rosenblum (1966a) and also by Wheeler 
(1975) was confirmed in several different strains of Staphylococcus aureus. 
On the basis of transformation experiments, it appears that the mutations 
in these strains affecting both fibrinolysin and a-hemolysin production 
occupy the same locus on the chromosome. An explanation for the nature of 
this mutational site is that it might play a regulatory role in the pro­
duction or elaboration of both proteins. However, several questions 
remain to be answered. One is why production of a-hemolysin 
among different strains of Staphylococcus aureus, and even within a par­
ticular strain, is subject to what appears to be an abnormally high incidence 
of loss? Elek (1959) stated that the level of toxin production in a culture 
reflects a balance between a-toxin positive and a-toxin negative variants 
present in the population, and in order to obtain high levels of toxin, 
the environmental conditions must favor the predominance of the a-toxin 
positive variant. It is plausible to assume that, even though the regu­
latory and structural loci involved in a-hemolysin production are 
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chromosomal, there could be a secondary involvement of one or more inte­
grated replicons. These replicons might be incapable of self-replica-
tion and therefore would be functional only when they exist as part of 
the chromosome, their stability as integrated replicons being affected 
by many environmental factors. Winkler et al. (1965) suggested such a 
dual control in their studies on g-hemolysin and fibrinolysin. The 
pleiotropic loss of extracellular products such as a-hemolysin and 
fibrinolysin also poses interesting questions as to how these multiple 
characters are regulated. Are the structural genes for these products 
under regulation of a single repressor, or are they subject to coordinated 
induction so that an inducer of one enzyme leads to the production of 
several? It is also possible that the hla locus examined in this study 
controls the transport of a-hemolysin and fibrinolysin across the cell 
membrane. 
Very little is presently known about the regulation of production or 
the process of release of the various extracellular enzymes in Staphylo­
coccus aureus. There also remain many questions about the physiochemical 
and biological properties of a-hemolysin and the possible roles that both 
a-hemolysin and fibrinolysin play in the pathogenesis of Staphylococcus 
aureus. The mapping of determinants affecting these products within a 
defined linkage group of Staphylococcus aureus now offers an opportunity 
to specifically construct strains so that many of these questions can be 
answered. Also a fine structure genetic analysis of this region, via 
transduction, may help to clearly define the regulatory and structural 
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elements involved and their role in the production and release of these 
extracellular products. 
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SUMMARY 
A preliminary screen of several multiply auxotrophic mutants of 
Staphylococcus aureus strain 8325 for their hemolytic activities showed 
that several of the mutants lacked the capacity to produce «-hemolysin. 
The identity of a-hemolysin was confirmed by the inhibition of its 
hemolytic activity by staphylococcal 3-hemolysin on sheep blood agar and 
also by neutralization with a-hemolysin antiserum. Genetic transforma­
tion identified the location of the hia determinant in strain 8325 to be 
between pur-110 and ilv-129 in linkage group III. Further transformations 
involving DNA from nonhemolytic mutants of strains Ps6 and 233 of 
Staphylococcus aureus confirmed the linkage relationship established 
among mutants of strain 8325 and indicated that the determinants 
affecting a-hemolysin production among various strains of Staphylococcus 
aureus are isoallelic. 
An explanation for the apparent spontaneous loss of a-hemolysin pro­
duction in strain 8325 of Staphylococcus aureus is difficult to reconcile 
with the fact that this strain is plasmid-free (Novick, 1967). Changes 
in the phage typing patterns among recombinants did not correlate with 
the production of a-hemolysin, suggesting that toxin production is not 
brought about by phage conversion. However, variations in the Pur-Hla 
cotransformation frequencies obtained between interstrain and intrastrain 
crosses suggested that a genetic element in this region of the chromosome, 
such as a defective prophage or translocatable element, may affect a-
hemolysin production. 
87 
The results obtained from screening nonhemolytic donor strains and 
recombinants for their production of fibrinolysin, thermostable nuclease, 
coagulase, lipase, and gelatinase suggest that the hla determinant is a 
regulator locus affecting a-hemolysin and fibrinolysin production. 
The ability of strains and recombinants to produce a-hemolysin, with 
few exceptions, correlated with their ability to produce fibrinolysin. 
However, there was no direct correlation between hemolytic activity and 
the production of thermostable nuclease, coagulase, lipase, or gelatinase. 
An overall assessment of the results shows that a determinant affecting 
both a-hemolysin and fibrinolysin production is common to different strains 
of Staphylococcus aureus. This determinant appears to be a regulatory 
gene affecting either the production or extracellular secretion of both 
a-hemolysin and fibrinolysin. A further genetic analysis by transduction 
may help to clarify the remaining questions concerning the nature of the 
genetic elements in this region of the chromosome. 
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